Content-Type: text/html

Reference sequence (query): batch____
Identities normalised by aligned length.
Colored by: property
HSP processing: ranked
Search cycle: 3
                                                                                                      1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         . ] 162
    batch____                                              bits   E-value  N 100.0%   1:162             MQSWYLLYCKRGQLQRAQEHLERQAVNCLAPMITLEKIVRGKRTAVSEPLFPNYLFVEFDPEVIHTTTINATRGVSHFVRFGASPAIVPSAVIHQLSVYKPKDIVDPATPYPGDKVIITEGAFEGFQAIFTEPDGEARSMLLLNLINKEIKHSVKNTEFRKL    
  1 UniRef50_Q01SW9        Transcription antiterminati...   164     9e-40  1  19.3%   2:162  66:239     -KKWYIIHTYSGFENKVQESLrdKIGQILIPTEEVVELRNGKKVTSKRLVYPGYVLVEMEMNDALWHEVKNTPRVTGFVGGGNSPVPLSADEVNSILYRqaERPRPKMTFEKNDSVRIIDGPFANFSGKVDEVNPErtLRVMVTIFGRATPVELEFLQVEKV    
  2 UniRef50_C7M2W0        Transcription antiterminati...   162     5e-39  1  20.8%   3:161  67:242     --EWYVVHCYSGYENRVRQNleDRIFEVEIPMEDVTELKNGRRVKVQRKVFPGYVLVRAEMDDEVWSAIRNTPGITSFVGSGSKPVPLSRKEVEAMFSFATPEELRPQpfEIGETVRVKEGPLADFVGEVAEVNADqkLKVLFNIFGRETPVELDFTQVSK-    
  3 UniRef50_Q6A6K1        Transcription antiterminati...   158     5e-38  1  21.2%   3:162 117:303     --EWYVLHTYSGMENKVKQNleDYIFETVVPTEEVVEIRNGARRTITRVYLPGYVLVRMDLTDDSWGIVRHTPSVTGFVGQSTTPIPLTFDEVVKMlsPKAKPKVEVADYEVGESVQITDGPFAGVPAQITEInnNQRIKALVEILGRSTPVDLEFNQIEKI    
  4 UniRef50_D1CD65        Transcription antiterminati...   153     1e-36  1  19.4%   3:162  29:199     --QWYVIHTYSGYEDKVKRDLqdRIRDIIVPTVEEIEIREGKRHKVQKKVFPGYVLVRMRMDDAAWNVVRYTPGVTGFVGSGTKPTPLDEKEVEKILQRMSEEPPKVKmlRLGEAVRIVDGPFTDFEGTVDEINEEkkVKVLISIFGRPTPVELDFLQVEKI    
  5 UniRef50_A5D5K3        Transcription antiterminati...   152     4e-36  1  21.7%   2:162   3:174     -KKWYVVHTYSGYENKVKANLEKRifRILVPMEDEVEIKDGKKKVSKRKIFPGYVLVEMIMTDDSWYVVRNTPGVTGFVGSGSRPIPLNDAEARQIIRQMgeEPRTRVDFTVGENIRVISGPFENFIGQIEEINMEkkVKVMISMFGRETPVELDFTQVEKI    
  6 UniRef50_A3EVT3        Transcription antiterminati...   152     4e-36  1  21.1%   2:162  11:184     -KNWYVIHTYAGFENRVKTSIEERVvqVVVPIQNVTELKEGKKKVSSRKVFPGYVLVEMEPTEEAIQFILATPKVTGFLGNGTTPIPMSSREVSELFDRIESGTAMpqHFSESETVRITDGPFQGFSGMISEVddHGKLKVLVSIFGRQTPVELDFLQVERL    
  7 UniRef50_Q1AU17        Transcription antiterminati...   150     2e-35  1  19.8%   1:162   1:176     MKKWYVVNTYSGHENKVRATLERRIeeIRIPTEQVIEIKNGKKVPTTHRQFPGYILVNVEMNDDTWRVIRQTPGVTQIVGSGDKPTPLSRAEVERLLHPEEPEKREkvDFDIGETVRVVAGPLSDFTGTISDIndQSKVKVLVSIFGRETPVELSFNQVAKL    
  8 UniRef50_D0LJE5        Transcription antiterminati...   150     2e-35  1  25.8%   3:161  18:188     --KWYVVHTHAGYEQRVRETLQQRAveILVPTLNVMEVVKGKRKTSTKKFFPGYIFVQMEFTDSVYHLIRNTPKVTGFVG-GNTPQPVPESEISVIHNTMSdkPRPKVMFEQGDNVRVTDGPFASFTATVEEVKPDkkLRVLVTIFGRATPVELDFTQVEK-    
  9 UniRef50_D0WPF7        Transcription antiterminati...   149     3e-35  1  23.3%   3:161  88:272     --RWYVLHTYSGYEKRVKQDLedYIFQIEVPMEEVFEIRRGQRKLVSRVRMPGYVLIRMDLTDDSWRVVQSTNGVTGFVGNGRTPVALSENEVVSMLTPvsPTPATLSPYAVGDAVTLTSEPWAGMPATVSEVdaNQRLTVLMTLVGQETPVELSFNQVRK-    
 10 UniRef50_B9KYX2        Transcription antiterminati...   148     5e-35  1  23.3%   3:161  27:196     --EWYVLHTYSGYENKVRQNlaDKVFEVVIPMQEEIEIRGGQRHTVQRKVFPGYVLVRMILDDESWHVVRNTPGVTGFVGVGNRPVPLDRAEAEaiRGAKAEQPKVRMTLLPGDVVRIIDGPFTDFRGVVDEVDNEkkVRVLVSFFGRETPVTLDFLQVER-    
 11 UniRef50_Q9CBK0        Transcription antiterminati...   148     5e-35  1  18.1%   3:162  38:228     --DWYVIHSYAGYENKVKANLETriFQVEVPTEEVTEIKNGQRRLVNRKVLPGYILVRMDLTDDSWAAVRNTPGVTGFVGATSRPSALALDDVVKFLLPSGSAKKdeVDYEVGESVTVMDGPFATLPATISEVNAeqKLKVLVSIFGRETPVELTFSQVSKI    
 12 UniRef50_P0AA01        Transcription antiterminati...   148     6e-35  1  16.9%   2:161   7:180     -KRWYVVQAFSGFEGRVATSLREHIkeVMVPTEEVVEIRGGQRRKSERKFFPGYVLVQMVMNDASWHLVRSVPRVMGFIGGtdRPAPISDKEVDAIMNRlgDKPRPKTLFEPGEMVRVNDGPFADFNGVVEEVDYEkrLKVSVSIFGRATPVELDFSQVEK-    
 13 UniRef50_Q9KGE7        Transcription antiterminati...   148     8e-35  1  19.3%   2:162   3:178     -KNWYVVHTYSGYENKVKTNLEKriFRVMVPVEEETEVKNGKSKQVSRKVFPGYVLVEMVMTDDSWYVVRNTPGVTGFVGsgSKPTPLLPEEVDAILRQMGMQEEreIDFQLKESVKVKEGPFANFIGTIEEIqdKRKLKVHVNMFGRETPVELEFTQIEKI    
 14 UniRef50_B4R8J9        Transcription antiterminati...   147     1e-34  1  19.4%   3:162  16:188     --KWYIVHAYSNFEKKVAESIREQAreILVPTEDVVEIRRGRKVNSERKFFPGYVLVKMEMTDEAYHLIKNTPKVTGFLGSGSKPIPVSEKEVERIVGAIEEGVERPKpfEIGEQVRVTDGPFASFNGSVEQVDEErrLRVTVSIFGRATPVELEYGQVEKI    
 15 UniRef50_C8XBG0        Transcription antiterminati...   146     3e-34  1  18.1%   3:162 123:306     --EWYVVHSYAGYENKVKTNLETRifQIEVPTEEVTEIKNGQRKQVQRKVYPGYILVRMDLTDQSWSAVRNTPGVTGFVGAtqKPSALTIDEVVKILTPTAPRKptEVDFSIGESVTVMDGPFATLPATINEVNAdqKLKVLVSIFGRETPVELSFSQVAKI    
 16 UniRef50_Q9CK84        Transcription antiterminati...   146     3e-34  1  20.0%   2:161   8:181     -KRWYVLQAFSGFEGRVATTLREYIkeVLVPTEEVVENVAGKRRKSERKFFPGYVLVQMEMNDETWHLVRSVPRVMGFIGGtdKPAPISQREADRILNRlsEKPRHRKEFQPGEEVRVTEGPFADFNGTVEEVDYEkrLKVSVSIFGRATPVELEFSQVEK-    
 17 UniRef50_P27309        Transcription antiterminati...   145     3e-34  1  21.4%   3:161 111:298     --EWYVIHTYAGYEKRVKANLEQriYQAEVPEEEIVQIKNGERKNVRQNKLPGYVLVRMDLTNESWGVVRNTPGVTGFVGNAYDPYPLTLDEIVKMLAPEAQEkiEVLDFEVGDSVTVTDGPFATLQATINEINPdkKVKGLVEIFGRETPVELSFDQIQK-    
 18 UniRef50_B0S060        Transcription antiterminati...   145     4e-34  1  21.2%   3:162  24:193     --KWYVVHTYSGHEGKVKVNIEKmiFEVVVPTEEYVSEVGGAKKLKERKIFPGYVFVKMTITDVSWYLVRNTRGVTGFVGPESKPVAVSEKEIQKFALKNQSYSKKEIDVNVGDNVNIVSGAFSDQVGIIEEINTEKAikVLISLFGRDTSVEISFDDIEKI    
 19 UniRef50_D2C1D2        NusG antitermination factor...   145     4e-34  1  71.6%   1:162   1:162     MRAWYLLYCKRGQLLRAKEHLERQDVVCLSPMIALEKIVRGKRTEVSEPLFPNYLFVEFDPEHIHTTTISSTRGVSHFVRFGNLPALVPQQVIEDLQHHQCTTHVDPETPQPGDQVTITEGVFSGLEAIYTEPDGEARSMLLLNLLNKQVRQSIDNRQFRKV    
 20 UniRef50_C1DDG1        RfaH n=1 Tax=Laribacter hon...   145     5e-34  1  31.7%   2:162   9:171     -MHWYLVHTKPRQEQCALQNLQQQGYQCYLPMLATEKLRQGRLVVSEEALFPRYLFIRLGlsDKSWAPIRSTRGVNQLVRFGTEPARIDDGLIERLRGHDAARANPEPLFRTGERVRLTDGPFAGIEGIYQMTDGESRVMVLIEFLTRPVVARVAPGSLRKV    
 21 UniRef50_Q0AUG6        Transcription antiterminati...   145     6e-34  1  16.9%   3:162  32:203     --DWYVVHTYSGYENKIkmNMQDKIFEVIIPEEQEVEYKNGKRKVTNKRIFPGYVIVNMIMDDDSWYVVRHTPGVTGFVGSGSKPIPLHQEEIDKIRRQMgeKKTMIIDIEIGESIRVKTGPFANFEGVVRELLPEkkIRVNISMFGRETPVELDYEQIEKI    
 22 UniRef50_D1NBR2        Transcription antiterminati...   144     8e-34  1  18.9%   3:161  14:191     --QWFVIHTLSGHENKVRDKILRqvYEAFIPTEKVAEVRQGKKTTTTRKLFPGYIWVRMDlnEKAWYFIRSVQGVLGFLGGDNKPTALTESEVEDIMRPAqpEVKPKIAFEVGEVVRIKDGAFENFEGAIQEIDNErkLKLMVSIFGRSTPVELEFWQVER-    
 23 UniRef50_Q5HRL6        Transcription antiterminati...   144     1e-33  1  18.6%   2:162   8:182     -KRWYAVHTYSGYENKVKKNLeeQIFRVVIPEEEETQVKDGKAKKLVKKTFPGYVLVELIMTDESWYVVRNTPGVTGFVGsgSKPNPLLPEEVRFILKQMgkEKTIDVELDVGEQVRIQSGPFANQIGEVQEIEADkkLTVLVDMFGRETPVEVEFDQIEKL    
 24 UniRef50_B8DVU5        Transcription antiterminati...   143     1e-33  1  18.8%   3:162 144:328     --KWYVLHTYSGYEKRVKSNIESriFQVEVPMEEVEKHTEKGKKVVTRVRVPGYVLIRMYPDENARRIVRETEGVTGFVGPSREPAPLSRKEVVSMMAPMIAShtLEVSYKVGDQVTVTDGPFTSMSAVVSDVEptQKLTVLVSIFGRDTPVELGFDQVQRL    
 25 UniRef50_A6FV14        Transcription antiterminati...   143     2e-33  1  29.3%   3:159   8:166     --RWYLVQFKPNSHKIAARNLQRQSFQTFLPMQDVTRRRAGKFHTAPQPLFPGYMFVSLDTIRGPWRQINATLGVSKLVSVAGRPQPVPDTLVNALLERCDDDGkpPETFSPGEQVTLRSGPFASFVATVEKMQPDRRVWVLLEFMGQATRIQVDADIL---    
 26 UniRef50_C4XIP4        Transcription antiterminati...   143     2e-33  1  13.8%   3:161  15:186     --RWYIVHTYSGFENRVELTLREmiKEVVVPTEKIIELVKGEKKTSTRKFYPGYVMVKMAMDDNSWHLVQSIPRVTGFIGGKNQPTPMRDSEAQKILSLmqEQPRPKYHFERGDDVRVIDGPFGGFNGVVEDVndKGKLRVSVSIFGRQTPVELDFVQVSK-    
 27 UniRef50_Q2LQ92        Transcription antiterminati...   142     3e-33  1  17.2%   3:159   4:173     --KWYVVHTYSGFESKVKQSLQERisDILIPEEDVVELVSGEKKTSKRKFFPGYILVKMELDDDTWHLVKDTPKVTGFIGSREKPSPIPDKDVELLKTRIDEgpKPKFKFEVGDHVTIIDGPFTNFDGVIDEVKAEkkLRVIVSIFGRPTPVELDFIQV---    
 28 UniRef50_P52852        Transcription antiterminati...   142     4e-33  1  20.1%   3:161 126:308     --EWYVIHTYAGYENRVKTNLedYIFQAEVPQEEVVQIKNGDRKTIKQNKLPGYVLVRMDLTNESWGVVRNTPGVTGFVGNAYDPYPLTLDEIVKMlaPQRKVEVQVLDFEVGASVTVTDGPFATLQTINEIKSDSKKVKGLVEIFGWETPVELSFDQIQK-    
 29 UniRef50_Q1WST1        Transcription antiterminati...   142     4e-33  1  23.6%   2:162  10:185     -KKWYVLHTYAGYENKVKENLESriFRVVVPEEEKHEtkTGKEKVEKLKTFPGYVLVEMVMTDQSWYVVRNTPGVTGFvgSGSKPAPLLDEEINHILHELGISSRHSNFdeVGDAVTIIDGAFSGLVGKITEIDTEkkLKVDIDMFGRETAAELNYDQVDKL    
 30 UniRef50_C8WBL1        Transcription antiterminati...   142     5e-33  1  18.6%   1:161   1:177     MSRWYIIHAYSGFENKVKEalQPLVEAIEVPTEQAVEVRRGKKVAVERKCFPGYVLAKLNMNEDVYHLVKNTPKVTGFLGFSGKPQPISDAEAEHILNHKAEAeqIKVDFEIGDQVKVLEGPFASFNGVVEDLddRARVKVSVSIFGRATPVELEFEQVER-    
 31 UniRef50_A4QBE9        Transcription antiterminati...   142     5e-33  1  20.1%   4:162 124:317     ---WYIIQCYSGYENKVKANleDDIFEVVVPIEQVTEIRDGKRKLVKRKLLPGYVLVRMDMNDRVWSVVRDTPGVTSFVGNEGNATPVKHRDVAKFLMPQekKPQVAVDFTVGEAVTILTGAFASVSATISSIDPeqKLEVLVSIFGRETPVDLSFDQVEKV    
 32 UniRef50_A6LPP9        Transcription antiterminati...   142     5e-33  1  19.4%   3:162  14:180     --RWYVVHTYSGYENKVKANLEKAIedIQVPMEEVVEEKDGKQKVSLKKKFPGYVLVKMLMGDEAWYVVRNTRGVTGFVGPGSKPVPLSDEEVESMGVLE---VPVEIDLEVGESIRIISGPLRDSVATIQEIIPDKrvKALVEMFGRETLAELDFNQVEKL    
 33 UniRef50_C1Z9H7        Transcription antiterminati...   142     5e-33  1  20.6%   2:161  29:203     -MLWYVLKITSNREKSIRDNLLRRIreILIPTEKVVENKNGKKKVVEHKLYPGYLMVQMILNDDTWYIVRTTGGVGDFTGSAGKPTPMQDHEIARMLQKQEQKQemKIEFAVGDIVKIKEGTFEGFEGPIDSIDenGKINVLVEIFGRSTPVELEYWQAER-    
 34 UniRef50_A4WZX9        Transcription antiterminati...   142     6e-33  1  31.6%   4:161  13:172     ---WYLVQTKPNAFRIAERNLLRQDFSVFSPTQNQTKKHGTRFRHTVQQLFPGYLFVRFNPEFPQWRAINATYGVSRLVTFGNIPSPVPHALIAGLRQRCANDGtpPEQLSLGDRVRIISGPFADYVATVEQIEPDKRVWILLDILGGQTKTQIQIAALQK-    
 35 UniRef50_C7RAP1        Transcriptional acivator Rf...   141     8e-33  1  41.2%   2:161   6:166     -KSWYLINSKPKQELRALEHLKNQEINCVLPVLEVERIIRGKRQKAIEPLFPGYLFVELQTNGQGWSKIRSTRGVRDFVRFGGVPGRVPDSVLEHLLILDTSFTPIETnpGAGDKVIITDGPFKDLEGVFKISNGEKRSIVLLTILGKVTEMELENKQLRK-    
 36 UniRef50_D1BP79        Transcription antiterminati...   141     8e-33  1  21.9%   2:161   5:176     -KKWYVIHTYSGYENKVKTTLELkiSRILVPLEDEIDEKDGVKKVVKRKIFPGYVLVEMEVNDRSWYVVRNTPGVTGFVGSATKPVPLSDSEVEHILKslDKKPTINVDVEVGETVRITSGAFEDKLGVITELNPEktLKLSVEMFNRDTEVELEFSQVEK-    
 37 UniRef50_C8NX40        Transcription antiterminati...   141     9e-33  1  18.1%   3:162 145:341     --SWYIIQSYSGYENKVKTNleESIYDVVVPIEQVFEkkNGKKKIVKRKLLPGYVLVRMDLNDAAWSVVRETPGVTSFVGNEGNATPVKHRDVAKFLMPkeEKPNVAHDFQVGEAVTILSGALASVSATINEIDPegKIQALVSIFGRETPVELTADQIERI    
 38 UniRef50_A9ND88        Transcriptional activator R...   141     1e-32  1  32.5%   3:159   6:164     --DWYLIYTKPRQERIAEENLERQGYRIYLPFIQVNRRRLGCYQLITEPLFPRYLFILLNIDKDNWGPIRSTRGVSALVRFGGIPAKVPPDFVQFLKNNeaSVPPKVSLFQKGQRVQIIDGVMAGYEGVFEMYSGAKRVTLLLDMVGKVTRVEVPLDSV---    
 39 UniRef50_B0RIR6        Transcription antiterminati...   140     1e-32  1  20.0%   3:162 157:345     --KWYVIHSYAGFERRVKSNIENriYQIEVPMEDVVEIKNGQRKMVNRVRIPGYVLVRMALNEDSWSVVRHTPGVTGFVGNAHNPTPLRFEEAFSMLkqAQRVVAAEVDFEIGETITIKEGSFAGLPGSISEIKPegKLTVLVSLFERETPVELSFDQVTKL    
 40 UniRef50_P35872        Transcription antiterminati...   140     1e-32  1  22.6%   3:161   4:183     --EWYAVHTLVGQEEKAKANLEKRifQVLIPTEEVVELrgGKKEVVRKKLFPGYLFIQMDLGDEewEVVRGTPGITGFVGAGMRPVPLSPDEVRHILEvkKEAPKAQVAFREGDQVRVVSGPFADFTGTVTEINPErkVKVMVTIFGRETPVELDFSQVVK-    
 41 UniRef50_B3QYK9        Transcription antiterminati...   140     1e-32  1  18.4%   3:160  29:199     --RWYTVRTYSGHERKVKEHLDKKIDdvYIPYERFVEVKDGKKKSRVKNAFPGYVLIEAVLDKQTRYLVLDAPSVIGFLGVGDEPTPLRPDEVKRLLEPEQEIevTKAPFEVGGAVKIIDGPFNSLTGVIQEVNAEkkVKVLINFFGRSTPTEVDFSQVK--    
 42 UniRef50_A3WUF1        Transcriptional antitermina...   140     2e-32  1  25.3%   3:160   7:168     --QWYVVQTHPHAEGKAAAHLRRQGFEVYLPRYARRRRHARRVDITASPLFPRYLFVAIDLVHQRWRAIRSTVGVTNLVYSGDEPAPVPDDVVRRLKQREDSKGCVqpRFSAGDTVRVVDGAFSDCLGLFESMSDGERVLVLLDLLGRKVRVTMDIDTIE--    
 43 UniRef50_A6F1J5        Transcriptional activator R...   140     2e-32  1  35.6%   2:161   1:159     -MTWYALQHKPSQGDRALTHLQNQDIACFYPKITVEKIKAGKRTKQLEPLFPGYLFVNLEQTDPMWAKLRSTRGILRIVSFANKPAAIPDDVIQHIKDSLHTVAEQG-GIKPGQAVELDEGPFKGIEAIFQAYDGEERAIVLISFMQKQQTVKVPLSTLHR-    
 44 UniRef50_Q0ACI7        Transcription antiterminati...   140     2e-32  1  32.9%   2:162  13:177     -RAWYLIYTKPRQEEAARDNLGRQGFHAWLPRVRVVKRRGTRRVPVVEPMFPRYLFVELDSAYQDWSPISSTLGVTSLVRFGGVPAKVPGPLVAALQARADEDDiaRQQPRAGDTVRVAHGAFAGYEAVFQARSGRERVLVLLEVAGKQSRVTLPADDIDPV    
 45 UniRef50_C4Z2Q9        Transcription antiterminati...   139     3e-32  1  21.5%   3:160   5:176     --KWYVVHTYSGYENKVKANIEkqILEVIVPLETVVEIKDGSKKAAQKKMFPGYVLVKMVMNDDSWYVVRNTRGVTGFVGPGSKPVPLTPTEIKNLGISLEEEQEVKPVikVGDKVMILSGAWEDTVGEITNINEGKqlTINVEMFGRETPVEIDFTDVK--    
 46 UniRef50_C7RDB1        Transcription antiterminati...   139     3e-32  1  20.6%   3:162  40:207     --RWYVVHTYTGYENRVNDKIQMMilEVTVPTEEYVEVKNDTKKVKTRKLFPGYVMVKMNITNKSWYIIRNTQGVTGFVGPDGKPVALTPAEVRKF-GVKDEAPILNINVNVGDDVNIISGPFEGFVAKVEEVDKEKgiKAFVDMFGRDTLIDLDFTDIETI    
 47 UniRef50_B1I1L1        Transcription antiterminati...   139     3e-32  1  19.9%   2:162   3:177     -KQWFVVHTYSGYENKVKANLEKRifRIVVPVEDEIEVKGGKRKISKRKIFPGYVMVEMILDDDSYRVVRNTPGVTGFVGsgSKPIPLTDAEANQIiqMEGDEPRIRIDLVPGEKVRVMAGPFENFIGTVDDVNYEkkIRVMISMFGRETPIELEYFQIEKV    
 48 UniRef50_Q82X31        Putative transcriptional ac...   139     4e-32  1  35.6%   2:161   1:163     -MHWYLVHTKPKQEKCAFQNLQQQGYRCYLPMLPVEKLHLGNLTVVDEPLFPRYLFIQLEQGdkSWVPIRSTRGVNRLVCFGSEPARIDDILIDLLRMQEAsqHKPERLFKPGERVRLTEGAFAGIEGIYQMAEGERRVMVLIELLSKPVAMRVSPTSLRK-    
 49 UniRef50_Q4K6G2        Transcriptional activator R...   139     4e-32  1  34.6%   4:162  84:239     ---WYLVQCKPRQDLRAEENLRRQGFHCYRPQRGCERVVQGRRQSGTESLFPGYLFIALEH-DASWAPLRSTRGVNRLVAFNGQPLAVPVSLIESLRQRVTDMDTSLPY--KGTRVCITEGCFADLEAIFESSIGDERVVLLLTLLNQQRRIELPLSSIRKI    
 50 UniRef50_A6W3A4        Transcription antiterminati...   139     4e-32  1  16.9%   2:161   3:176     -KRWYVVQAYSGYEKHVMRSLIERVqdILVPTEEVVEIRDGKKRKSERKFYPGYVLVQMDMNDASWHLVKGTSRVLGFIGGtdKPSPITSREADAILQRVSDgpRPKTLFEVGEVVRVNEGPFADFNGVVEEVDYDkrIKVAVLIFGRSTPVDLEFSQVEK-    
 51 UniRef50_C4LL90        Transcription antiterminati...   138     4e-32  1  20.0%   3:162 154:352     --EWYIVQCYSGYENKVKTDLeeQIHEVVVPIEEEVEVKDGKRKVVKHKLLPGYVLMRIELDDASWSVIRDTPGITSFVGNEGHPTPVKIREVAKFLLPPesADKVKVDYEVGEAVTVLSGPFASVSATISEIDAEnkLKALVSIFGRETPVELDFDQVEKI    
 52 UniRef50_A0KGQ9        Transcriptional activator R...   138     4e-32  1  42.0%   1:162  18:182     MKKWYLAYCKPKEEARARAHLEAQGIESYYPMVEIEKLRRGKRVPVREPMFPNYLFIYVDLEEVTPVTLKSTRGISRIIHFGREWTSISSQLVYQLMSRDDSDEARASypTQGDKVLIESGPLAGFEAIYLEPDGDKRAILLVSLLNQETSSSFDNQSFRRL    
 53 UniRef50_D2RNN9        NusG antitermination factor...   138     5e-32  1  18.6%   2:162   5:190     -KHWYVIHTYSGYENKVKMNLeeQIFQVLVPMQNEVDAKDDKQKVVARKVFPGYVLIEMIVDDRTWYAVRNTPGVTGFVGTGTKPIPLSDREVERIlaVEEPVVRMECPVGLNDTVRIKAPGFTDMVGTVAEINDeqKIKVMVEMFGRETPIEVKFTQVEAI    
 54 UniRef50_Q7MMR1        Transcription antiterminato...   138     5e-32  1  45.0%   1:160   1:165     MKKWYLLYCKRGEQIRAKQHLENQGVECFYPTIEVEKILRGKRQIKSEPLFPSYIFVRFDFegPTFTTVRSTRGVVDFVKFGAHPKELQGDLIYELKLLEQEGHQssNLPKPGDSIKVKSGQFAGIEAIFQEQDGETRSIMLVKMISQTVPVSIENSDLE--    
 55 UniRef50_D1B6U2        Transcription antiterminati...   138     5e-32  1  20.5%   2:162   6:180     -RRWYIVQTYSGYENKVKANLEQRifNVLVPVEEKVFVKEGRAKRVRRKVFPSYVLVEMIMDDQSWYVVRHTPGVTGFVGSGNHPIPLTDREVakIGLPADRKPKVELDIEVGDTVRVKSGPFEGCVGPVVEVDPDkrVRFSVTVFGRETVAEAGHEDLEKV    
 56 UniRef50_P0AFW1        Transcriptional activator r...   138     6e-32  1 100.0%   1:162   1:162     MQSWYLLYCKRGQLQRAQEHLERQAVNCLAPMITLEKIVRGKRTAVSEPLFPNYLFVEFDPEVIHTTTINATRGVSHFVRFGASPAIVPSAVIHQLSVYKPKDIVDPATPYPGDKVIITEGAFEGFQAIFTEPDGEARSMLLLNLINKEIKHSVKNTEFRKL    
 57 UniRef50_C2KN14        Transcription antiterminati...   138     6e-32  1  19.4%   3:162  90:279     --RWYVVHTYSSYEKRVKQNIEQriYQVEIPMEEHIEVKAKSRRKVLRPRIPGYVLVRMDMEENSWRLVKDTPAVTGFVGNQQDPVPLTLQEVIDMLAPTAAQaqIVTDFEVGQGVTITSGPFETMTATIAEIYPdsKLKVLVTIFERETPVELNFDQVEKI    
 58 UniRef50_Q1UZH8        Transcription antiterminati...   137     1e-31  1  16.8%   1:161   1:174     MKNWYIVQSHSNFENKVAGLIKekIEEIVVPTHDVTEVKRGKRIQRKKKYFPGYVLIKSEMDNDLYHLIKNLKRVSGFLGSKGIPVPVSDKEIEKILGQIKDGVAQpiEYSIGEKVQVVDGPFASFSGMVEDIDEEkrLKVSVSIFGRPTPVDLEYNQVEK-    
 59 UniRef50_P57151        Transcription antiterminati...   137     1e-31  1  15.6%   2:161   7:180     -KRWYVLQAFSGFESRVAQSIREHVkeVMVPSQEVVEIRGGQRRKSEYKFFPGYVLIQMKMTDSTWHLIRNVPKVLGFIGgsDKPSPISDKEVEIIINRlgNKPRPKTLFEPGEMIRVNDGPFADFNGVVEEVDYEkrLKVSVSIFGRSTPVELDFRQVEK-    
 60 UniRef50_Q1QVL5        Transcription antiterminati...   137     1e-31  1  35.2%   3:161  18:180     --RWYVVQCKGGESFRAGEHLTNQGYRVFHPVLEVQKKRRNKLVWIAEPLFPHYLFIHLDRVASNWRPIRSTRGVLKLVGFGDEPLPVPDALIETLAARAHLDEASRtyFRPGEIVEITEGPFQALQAVFDTQQGDERAIVLLNMLHHQQRLELPVGHLRR-    
 61 UniRef50_B2KEU4        Transcription antiterminati...   136     2e-31  1  18.6%   2:162   5:177     -KAWYIVHTQTGHEDKVRenFGDRIFQVLVPTEDVVEVKQNKKVQRKRKFFPSYVLVEMDLTSEAYWFIRNVSGVTGFLGDPN-PVPLPEEEIAAIlqPGSGKPKHVIEFEAGENVRITEGPFKHFIGVVQEVNNQkkLKIMVNVFDRSTPVELDFLQVEKI    
 62 UniRef50_D0MHN6        Transcription antiterminati...   136     2e-31  1  19.9%   1:161  10:184     VRKWYVLRTFSGHEKKVKQYLEREIeqILIPTETVFELRGGKKRTRERTFFPGYILIEAVLDRELQHLIANMPSVVGFLGSGDQPTPLRPDEVRRILGKVDegEQPEIPFKPGDVVRIIEGPFNNFTGVVEEVYPDkkLKVMVSIFGRKTPLEVDYLQVER-    
 63 UniRef50_C9M8Z2        Transcription antiterminati...   136     3e-31  1  22.5%   3:162  12:185     --QWFAVQTYSGYENKVKNNLEQRifRVLVPMEDVVVVKDGKSKQMSRKLFPSYVLVEMIMDDQSWYVVRHTPGVTGFVGAGAHPLPLSDEEVRDVLVkeAETPQIVVECQVGDSVRVKSGPFVGAVGVVSDVNTsgKVKFVLSVFGRETEAEVNHTELERV    
 64 UniRef50_Q48H23        Transcriptional activator R...   135     4e-31  1  33.8%   3:162   9:166     --RWYLIQTKPRQEARAEEHLRRQHFQCYRPLQ-VDVKKTAARVQADEPLFPGYLFIQMDQVQDNWYPIRSTRGVSRIVTFGGHPVPVRDHLIEQIRQRLST-PAPKARFIQGDPVMITTGSWSDVEAIFLSEDGTERAVILLNMLQRQQKMGLPISSLSRV    
 65 UniRef50_A0Q872        Transcription antiterminati...   135     4e-31  1  16.9%   2:161   1:175     -MLWYVVQVHSGYEKRVKAQLEENIerILVPTENVVEMKGGQKRKSERKYFPGYVLIEADLSTDAWNLVKSVPRVLTVVGSKGKPIPLSKAEVDRILGFVEgePRLRKSYHVGEVVRVLEGPFNDFTGVIEEVNYEkrLRVAVSIFGRSTPVELEFSQVEK-    
 66 UniRef50_Q1YPV4        Transcriptional activator R...   135     5e-31  1  42.1%   1:159   1:161     MESWFLLQTKSKQEGRAVENLERQGVKSFCPMIKVEKLSRGSRVVKEEALFPGYLFVNFDQSSVSSTTVRSTRGVSHFVTSAGLPVKVPESLINQLMLRTdnDETVSSLPSKGERLQIIDGPFRGLNAVFSQPDGDRRAIVLINLLNQQVSASLPFASL---    
 67 UniRef50_C9LQP9        Transcription antiterminati...   135     6e-31  1  19.9%   3:158  35:200     --RWYVIHTYSGYENKVKDTLTRkiIQILLPMHDEEEVKDGEKKVVSRKVFPGYLLIQMEVNDRSWYVVRNTPGVTGFVGTTTKPIPLSDEEAKRIIEGKDKKQTAKTDAKVGDTIKITRGPFADRSAVVLDvdDRSKIKADISNFGTTTTIELEVGY----    
 68 UniRef50_A1WZB7        Transcription antiterminati...   135     6e-31  1  29.1%   4:161  15:174     ---WYLVYSKPRQEERAWWNLDHQGFRCFLPMARFRRRRQRRYQTVIEPMFPRYLFIRLAAGLEDWSPIRSTTGVSGLVRFGTWPARVPDGLVDTIRARIEDGHCdpEPLQPGERVRVLDGPFQSYEGIFRASRSDERVMILLDVAGQHTTLTVSQHQIER-    
 69 UniRef50_B1I6V9        Transcription antiterminati...   135     7e-31  1  24.4%   3:162   4:168     --QWCAVNTKPKKEDFAARQLEAKGLEVFLPRISVTRKRGASKFSLWEPLFPGYLFVKLLPEPVQVQRVNWTPGVRRLLCAGDTPVPVPDEAIALIRQRVGPgpKPQAEFPAGSRVAVRHGPFAGLLGVVEkmSGRGRVRVLLELLQRQTAVEIDAVDLDRL    
 70 UniRef50_P65591        Transcription antiterminati...   135     7e-31  1  18.6%   2:162   3:177     -KKWYVVQAYSGFEKNVQRILEERIaqILVPVEKVVDIRNGRKTISERKSYPGYVLVEMEMTDDSWHLVKSTPRVSGFIGgaNRPTPISQREAEIILQQVqeKPKPKVEFEVGQQVRVNEGPFADFNGVVEEVNYErkLRVSVQIFGRETPVELEFSQVEKI    
 71 UniRef50_A6CA55        Transcription antiterminati...   134     8e-31  1  18.2%   4:162  22:194     ---WYVLKVQSNREKSIRDALLRGIkeIIIPTEKVVETKGGKKRVFERKLYPGYLMIQVELNDDSWYLVRSTNGVGDFTGAAGKPIPMQEHEIARMLGREESKEETPvdFQVGDVVKVKDATFEGFEGTIDAVDesGKVTVLIEIFSRPTPTELEYWQIEKV    
 72 UniRef50_Q1RHC5        Transcription antiterminati...   134     8e-31  1  20.0%   2:161  18:188     -KKWYVIHTASGAENRIKRIMLERIsdILVPVFGVSEVKRSKNVKVEKKLMPSYILIKMNMTDKSWHLVKNIPGVTGFLGSKTTPKALTESEIQNIRLETEAKEAKDAkyEVGEIVTVTEGPFETFTGTVEEVDQEkrLKVSVSIFGKATPIELSFTQVKK-    
 73 UniRef50_B9CLA2        Transcription antiterminati...   134     1e-30  1  15.2%   2:159   3:180     -KRWYVLHTYSGYENKVMNDLedAVVDVQAPGEMVTEVKKRGEKDveVKFYPGYVLVRMELDDNTWSVVRNTPGVTGFLGVDGKPSPLRREEFNKMMRRSGGkkRVTTDVEVGQSVHVLSGPLADFDGIVSEVNAegKIKVMLTIFGRETPVELTLDQI---    
 74 UniRef50_C1A6N2        Transcription antiterminati...   134     1e-30  1  23.4%   3:160   5:179     --RWYAIQTTSGHENKVQRLIQRKirQALVPTQQVVEIKNGKKVTVERKIFPGYVLVEMVASQDTLHEINAIQGVIKFVGKDKDPMPLRDDEVRRLLGQADPADETPvpFLVGQAVAITEGPFADFNGTVEEILPDkkVRVSVSLFGRPTSVELDYLQLR--    
 75 UniRef50_Q9ZK20        Transcription antiterminati...   134     1e-30  1  18.5%   1:162   1:175     MMDWYAIQTYSGSEQSVKKAIEnrIQEIIVPTEDIIEvkKSKTKVMERSLYPGYVFIKVDLDTVLWHKIQSLPRVSRFIGENKKPTPLSEADIGHILEKMNNrpKPKIFFEQGEVVRVVEGPFANFTATVEEYdeHRKLKLNVSIFGRTTPIEILYSQVEKI    
 76 UniRef50_A3ZLI3        Transcription antiterminati...   134     1e-30  1  18.0%   2:162 118:294     -MDWYILKVQSNREKSICANLWRRVkeVMVPTEDIVEFKNGKKKITKRKLYPGYIVVHMAINDDTWFLVRETGGIGDFTGAAGRPTPMLAHEVERITKKVEDEETGEEpfKLGDHVRITEGTFENFEGDVEGIDenGRVTVMINIFGRTTPVEMEHWQMEPV    
 77 UniRef50_Q9CDV7        Transcription antiterminati...   134     1e-30  1  23.9%   4:162  13:183     ---WFVIQTYAGYERKVKEDLLEriLRVEIPTETIRTEVNGKMKEVEENLFPGYVLVEMNMTDEAWFIVRNTPNVTGFVGSHgkPTPLFEQEIQDILVGMGKVVREIDfvFVGKRVRIVDGAFSGFEAPITEINGDK-LTLTVDMFGRATPVELDMHQIEDI    
 78 UniRef50_Q83MQ7        Transcription antiterminati...   133     1e-30  1  20.8%   3:161  36:215     --KWYVVHSPAGFERRAKANLeqAIYQVEVPMEDVVGIRNGQRKMITRVRIPGYVLVRMDLNESSWAVVRNTPWITGFVGNMHQPVPLSFEEVFDMlrQKRSVTVSDVDLEVGETVVIKTGSFAGLPGTISEIKPegRLTVLISLFERETPVELAFDQVEK-    
 79 UniRef50_Q2WBC3        Transcription antiterminati...   133     2e-30  1  25.6%   1:160   1:164     MESWFVVHTHANAEKIAAGHLQRQHFDVYLPQYSKRRSHARKVEWVKAPLFPRYLFLRMDPDLTPWFSIRSTVGVHSLVCRGGMPVPLGQVIIDEIRGREDDSGLVsmPFASGQRLEIVEGPLAEQLGLFQGLDDMNRVVLLLDLLGRQVRVRVPLEAVR--    
 80 UniRef50_A4XLK3        Transcription antiterminati...   133     2e-30  1  22.0%   3:161   7:174     --KWYVVHTYCGYENKVKANLEkkILDIRIPTELVTEIKDGKKIVKEKKKFPSYVLIKAVMDNDIWYTIRNVRGVTGFVGPESKPTPLTDEEIEAM-GIKEEEVVEVFDIEVGDNVKIVAGPFADFYGPVIDINKekKVKVMLNLFGRETPVEFDYHQVEK-    
 81 UniRef50_B3EL56        Transcription antiterminati...   132     4e-30  1  14.4%   3:162  19:191     --RWYALRIYSGHERKVKeaLEDKILQVYVPYEKFVEVRNGKKRSLTKNAFPGYVLIEAILDKQTKNLIMDIPSVMGFLGVNDIPTPLRPDEVEKILEPESTVEQreAPFRVGDTVKVIDGPFSSLTGVVHDVceRMKVKVMISFFGRSTPTELDFSQVKSI    
 82 UniRef50_Q0FE68        Transcription antiterminati...   132     4e-30  1  25.2%   2:160   3:163     -KEWFILQFKPNSHHQATKNLTRQGFETFLPLTDITSRKTSRFINTTRPLFPGYMFITFDRTKPEWHKINNTYGVSRLVTFNSNLKSIPTTLVENLMVRCdsKILPVENLKKGDQVKILHGPFANFIATVETYETDQRIWVLMDLMSRKTKIQTPLDALE--    
 83 UniRef50_Q3J8A9        Transcriptional activator R...   131     5e-30  1  35.4%   2:162   9:172     -KFWYLIYCKPRQERLAQENLERQNFETYLPLVRQMRRRAYRRIATVEPLFPRYLFIHLDTEKDNWGSIRSTIGVISLVRFGAQPAHVPDTLIRELQTHEGSddLASPDFRKGQQVLVEEGLLAGHEGIWLTSNGKKRAHILLEIMGKQIKTEVNENWLKRL    
 84 UniRef50_Q6AP83        Transcription antiterminati...   131     5e-30  1  17.7%   2:159   3:174     -KQWYILQAHSGFEEKVKLTLEDRIkdILVPTEQVVEMVKGSRKTSSKKFFPGYMLINMELTDETWHTveNMPRVVGFVGDDRNPMPLSDEEAAKIIGRIQEgpRPKVIFDVGENVRVIDGPFSNFQGVVDEVFPDkrVRVMVSIFGRETPVELEFVQV---    
 85 UniRef50_Q3KCF2        Transcriptional activator R...   131     6e-30  1  32.1%   3:161  10:169     --NWYLLQCKPRQDERAHLNLLQQNYVVFHPQLVSERVIRGKRQRVQESLFPGYLFIQLSR-DDNWAPLRSTRGVSRFVEFNHGPATVAEHVIEHLRARCLESTLSEPdlKPGENLQIVSGPLAPLEGVFLGLHGTDRVMILLQFLNREQPVCLPLSVIER-    
 86 UniRef50_B2UQY7        Transcription antiterminati...   131     6e-30  1  18.1%   2:161   9:188     -EQWYVLHVLSGQENSVRDRIIRkiYRVEVPTELISEVRNGKKTERHSKLFPGYVYANmtLNKDLWYFIQQIDGVISIAGSRNAPLPMRKREVEDLLPLLDAEAvpKVEFAVGDPVRVCEGPFQSQEGTIEEIDPEkkLRVSVSIFGRATPVDLEYWQVEK-    
 87 UniRef50_D2R5P4        NusG antitermination factor...   131     7e-30  1  16.2%   3:162  91:267     --EWYILKVQVNREDSIKASLLRRikDVVVPTEDVAetKTGKRRVVKKKIYPGYILVNMVFNDETWFIVRETSGIGDFTGAMGKPTPMDPKDVERILRSSknQVRTAIPFKVGDRVRVKEGYFQNFEGDIDGIdaNGRVTVMINIFGRSTPVELEHWQIEAV    
 88 UniRef50_A1T084        NusG antitermination factor...   131     7e-30  1  39.4%   3:162   4:167     --QWFVVYCKSREELRAQRNLENQGVYSFFPKICKEKILRSKKKVVEEPLFPSYLFVNISKNDEKFSAIRSTRGINNFVKFGLSIATIPDQQIKKIEQLCHVnvNSEDVYQNGDKIEILSGPFKGLTAIFNIEDGLERSMLLLKILNQDNNISFKNSALKKV    
 89 UniRef50_Q2LVW1        Transcription antiterminati...   131     7e-30  1  19.9%   2:162   1:167     -MSWYAVHTRSRHEDKVFTGLVQKSITTFLPKIEVWSKRKDRRKRIMTPLFPGYLFVDMplDNQAKLDVLKTFGVVRILgtGSAPIPVPDDKIDAIRRIVDseVQNLQYPHVGEAARIVDGPFKGIEGTVIKTDYDKDlvVTIELLQRSVAIKLDSSQIEKI    
 90 UniRef50_B1KMD8        Transcriptional acivator Rf...   131     8e-30  1  32.1%   1:162   3:179     MKAWYLLYCKPRGEARAVHNLTLQNIDTYLPTIGEEKRVKGEVSIKRIPLFPGYLFINIDPQVTSVARIHSTRGVGRIVGCNELMTSIDDSIIHSIRLREHkdGSSTVEINPGDQVKFTEGPFADLEGIFAEKSGDKRCHVLFEIMGQKKRVSVPRDSIKPV    
 91 UniRef50_B1ZPC3        Transcription antiterminati...   131     9e-30  1  20.1%   3:161  12:189     --QWFALHTLSGQENKVkeELDDSIFEVLLPTEIVSEVKGGKKSTKVRKLYPGYVFIQMRLYGEdwYFVKEVAGVIGFVG-GDRPAALRQSEIDEIRARIegKEVPKVQYSVGEEVKITDGAFASLTGRIDEIDPErkLKVSVSIFGRFTPVELEYWQVQR-    
 92 UniRef50_A0XZ39        Transcriptional activator R...   130     1e-29  1  39.4%   1:160   1:159     MESWYLVICKPRQEERAKANLNNQGIEAFYPILTTEKLVKSRRTVKQVALFPNYLFVCLDSKNGPFAAVKNTRGIGGFVTYGANYQVVPLAIIEHLNNHTSNTVESQL-PKQGDAVSVSNHSFKNIDAIYKEPDGDMRSILLINLLNKQVEMSVDNTDIE--    
 93 UniRef50_B8FH43        NusG antitermination factor...   130     1e-29  1  18.9%   2:160  10:169     -KQWYALYTKSRHEACVNNYLAARSIESFYPQMRILSRRKDRRKMIDVPMFPGYLFVRAALRSRQHLSILKAPGAVTLIGNTRGAIAIPEDTISSLRIVSQKEALEtpCYHAGDLVLIVSGPFAGVTGVFMRNKGGGKILVNIDALGQSVAVEMGGADVQ--    
 94 UniRef50_A7BC06        Transcription antiterminati...   130     1e-29  1  18.1%   3:162  72:254     --DWYVIHTYSGHERKVKANLEQRifAVEVPDEYVMEYRGNAKKRVRHVRIPGYAIVCMDFNEASYRVVKETPAVTGFVGDQHNPVPLSIDEVVMLLTPNVLEEAAetQFEVGEIVTVTDGPFETMSATISEIMPeqKLKVLVTIFERETPLELGFDQVEKL    
 95 UniRef50_P68893        Transcription antiterminati...   130     1e-29  1  22.2%   2:159   7:176     -KGWFVLQTYSGYENKVKENLLQriLRVEIPTQTVNVEKNGQTKEIEENRFPGYVLVEMVMTDEAWFVVRNTPNVTGFVGSHgkPTPLLEEEIRAILLSMGqiDVFDTNIKEGDVVQIIDGAFMGQEGRVVEI-ENNKVKLMLNMFGSETVAEVELYQI---    
 96 UniRef50_B3E158        Transcription antiterminati...   130     1e-29  1  18.8%   2:161  21:199     -MQWYALHVLSGQEEKVKKNLEKRIkeVVIPVERVSEVRKGKRIEINRKLYPGYVFLQIQLRdrAWYFVRETSGVIGFA-DGDNPLPMPREQVEGMLRQIQesALPKTVFSVGDRVKVGDGPFLNSEGVIEEVdeRGKLRVSVNIFGRSTPVELEYWQVEK-    
 97 UniRef50_Q14PQ9        Transcription antiterminati...   130     2e-29  1  18.8%   3:162  32:216     --KWYVINCYSGHEDRVRDDLIQRvfDIRVIKETVSAKKGGKLIEKEKNLYPGYIFINMIMNDEAWYIVRNTTGVTGFIGSSgkPFPLTDQEARTMLSkkKVKKVFVANFEVNDYVRILSGTFTEMEGQVTKIDTSKGIavNLEMFGRLTPTEVEFDQCEKI    
 98 UniRef50_Q6MJ02        Transcription antiterminati...   130     2e-29  1  18.8%   2:161   3:176     -KKWYIVNVQTSCENTAKKAIEEKIkeILIPAESVVELVKGQKQTKSRKFFPGYIFVQMFLNDETWHLVRNSSKVTGFVGGTkrPPEVPEAEVLRVTQQmaEKPRPKVKFAVGENVTVIDGPFSNFQGTVEEINEDkkLKVLVSIFGRPTPVELDYIQVEK-    
 99 UniRef50_A0LIY4        NusG antitermination factor...   130     2e-29  1  17.6%   2:160  39:200     -KSWFALYVQVKHEKEVVRRLDQKSIDCFLPLMECWSKRLDRRKRITLPLFPGYVFVHTVLDNYTNVNILKTPGALSILKNSEGPLPIPVYQIENLQTILNSSKslHPYLKEGEWVRVIRGPLSGCVGILKRHAPKkrLVVSVDCIRQSVSVELDVEDVE--    
100 UniRef50_D2MPP9        Transcription termination/a...   129     3e-29  1  17.5%   3:162  19:193     --RWYVVNTYAGHENRVKDNLEKRlfRIFVAEEEEIVIKKNNKSEVKKvmFPGYIFVQMKMTDQAWYVVRNTPGVTGFIGSSgkPFPVSEDEMESILRRMGHGDQkvVDFQVGDNVKILTGPFANMIGRISAMNDQTQIATVMtlFGRETPNEISYGDLQKL    
101 UniRef50_Q87A27        Transcription antiterminati...   129     4e-29  1  15.5%   1:161   1:184     MKRWYVVHAYSGFEKSVAQALRDRIsdVLVPAEEVVEMRSGQKRRSEHKFFPGYVLIQIeiDNECWHLVKETPKVMGFIGGtdRPLPISSDEADVILRRVQDgpRPKVLFEPGQMVRVIDGPFNDFDGLVEEVNYEkrLRVAVLIFGRPTPVDLDFGQVQK-    
102 UniRef50_C8QDS8        Transcriptional acivator Rf...   129     4e-29  1  45.8%   1:155   1:156     MENWYVAQTKYAQEKRAQQQLLSQGVTCLFPVFSEVrqNGGIRRIAEQPLFPNYIFVRFDPEVVHTTAIKATRGVSSLISFGGLPSVVPDSVIIRLNQGWERAPLNTDAPVHGDRVVIRDGAFEGLEAVWYEPDGLKRAMLLLTLMNREVRVPVE-------    
103 UniRef50_B8E0K4        Transcription antiterminati...   128     5e-29  1  23.3%   3:161   5:174     --KWFVVHTLAGHEHKVKAILERQvfEIVVPEEKVMTVKGGKKRIQVKKVFPGYLFIRMIEDEDVIRMIRNTTGVTGFVGTPGRPSTLNPQEEHWIRRFLEQKEIRPekVKKGDRVYIKSGPFMGYEGFVDEVYPEktVRVLLSIFGRETPTEIDHTQVEK-    
104 UniRef50_Q0F316        Transcriptional activator R...   128     6e-29  1  29.1%   2:152   4:160     -KQWFAIRVKPRQESLAAANLERQGFEVYLPMINTRISHAGKVSWQPRPFFAGYLFVHLSIDEQRWTTIRSTVGVLAPVAFGTFYPPLSDQVIALLQARHDesSTPESPFRAGEKVRMLDGAMKGLEGVFIEMRGQDRALILLDWMKKSMRV----------    
105 UniRef50_B8KUX9        Transcription termination f...   128     7e-29  1  35.3%   2:151  21:170     -RRWYVVASKPRSEGVAKSQLERQGFVTCAPRIKLRKRQRGKWQQVIEPLFPGYLFVALRLGVDDPAPIRSTLGCIGLVRMGREFVPVPEAVMQPLLSIGESPDASEAVFQPGQAVRFEAGPFEGLSGIFKMPKGQDRAEVLITLLGSSAR-----------    
106 UniRef50_C0QWX1        Transcription antiterminati...   128     8e-29  1  18.0%   2:162  11:195     -YKWYIVHTQHGYENKVRERIEKriVDIYIPSETVTSTKNGKKVSKEEFFYPGYVLVKMVMNDATQSMVRRTPGVAGFIGSHAtpTPLSESDVARikSKTGINEIIGMEFDIGEKVQVIDGPFNGLNGIIENIndKGRVTVKIEIFGRSTPTELEFSKVKKL    
107 UniRef50_B6G0A9        Transcription antiterminati...   128     8e-29  1  19.4%   3:162   8:180     --KWYVVHTYSGHENKVKATIERAVItvVVPTENVVEkpKGNEKIRQRKVYPSYVLIKMIITDESWYVVRNTKGVTGFVGPGSKPVPLSEEEVIAMGIELPAQEVvdVDFEPGDVVKIINGSFAGNVGTVEEVNAEKkvKLLTEIFGRKSPVTIGIQSIEKI    
108 UniRef50_Q2JTQ7        Transcription antiterminati...   128     9e-29  1  20.8%   3:161  40:221     --RWYAVQVASGCENKVKSTlaDQIVEVVIPKRTGFKlrSGKRQEQEEKIFPGYVLVRMDLNDDTWMVVKTTPNVINFVGTEErpRPLSPSEVQRIFSSVEVEEVpkIDMAPGDRIEVLSGPFQGFYGEVVDVSPErkLKALISIFGRDTPVELEFGQVRK-    
109 UniRef50_C7GYQ7        Transcription antiterminati...   126     2e-28  1  18.1%   3:162  32:198     --RWYVVHTYSGHEQKVKDNILklILKINIPTEEKVEIKNGQRKSRKVKQFIGYILIKMKVTNESWYVVRNTQGVTGFVGQGKKPVPLTAEEVRRLGI---EKVIVNLKIKPGDTIKVINGPFEGHNGEVIEVdeHETLRAKIFMFGRETPVDLEYEQIDKL    
110 UniRef50_A6GM36        NusG antitermination factor...   126     2e-28  1  29.8%   1:161  13:178     MAQWYVMYTKPRQETVALENLQRQNYNVFFPQARVQKRKTGqtVQVVEPLFPRYMFIQLEVGVSDFSKLRSTKGCVDLVKFGGKPSVVPIELIELIQHQLDSDSVLdnELEVGGEVRVAEGPFEGMMGKIAARKSDQRVIVLLNVLGAERSVELAQSQLDK-    
111 UniRef50_Q1Q029        Similar to transcription an...   126     2e-28  1  17.6%   4:162   8:168     ---WFAVHTRSRHEKQVDSFLREKNISSFLPLVKTISRRRDRKKFIDVPLFPGYLFVNITLDNL--YEIKSTRGVVRIIGNEDdpSPIPDAEINNLKTLINSNVAIDpyLQKGTKVRVVSGPLIGLEGLLVKRKTNYRVVVSIDILQKSTSAEISIADIESI    
112 UniRef50_C7PUS0        NusG antitermination factor...   126     3e-28  1  21.9%   3:162  14:173     --KWYVAYTRANFERKVAKDIVDQQIEHYLPLRRETRKWSDRLKQIEVPLFPNYIFVKIKLQHKV--NILGIPGVLSLVSFSGQPVSVSEREIQHIRKIEERGqaLEYYYCVGDRVRITQGIFTGMEGILLRKSGQMRFVLKLPAISQAVSVEIEGDQLERI    
113 UniRef50_Q01XJ6        NusG antitermination factor...   125     4e-28  1  20.1%   4:162  20:178     ---WFAVKVRSNFEKKSADILREKGYQEFAPSYPSRRYWSDRVKVIDQPLFPGYVFCRFHPN--HFLPVLQTAGVVQIVGFGGKLAPVDEVELASLRTLMNSSLpqREFLHVGRKVLIRRGPLAGVEGILEEIRKGYRIVVSISLLQRSVTAEIDANWVTTV    
114 UniRef50_P36265        Transcription antiterminati...   125     4e-28  1  18.9%   3:161  22:203     --HWFAVQVASGCEKRVKLNLEQRilQVEIPKTPIVKIRkgARVQGEEKIFPGYVLIRMIMDDDAWQVVKNTPHVINFVGSEQkpMPLSHGEVERIFRHVDeePVVKIDMEIGDHIMVLSGPFKDFEGDVIEVSPErkLKALLSIFGRETPVELEFTQVEK-    
115 UniRef50_B3T6R2        Putative transcription term...   125     4e-28  1  17.5%   3:162  97:270     --KWYILQAYSGYEGRVEQTIREKLreIFIPSEDIIRTKEGKKRKVNQKYFPGYVLIHMELTPELWHLLMNVNRVSGFIGGtkKPLPLDEKELEEIRSQVNEgkATEDEYSVGQKVTITEGSFGNFSGTIDEVneRRKLKVLVSIFGRPTPVEVEFENVKHV    
116 UniRef50_B0SAG6        Transcription antiterminati...   125     4e-28  1  17.0%   2:160   7:181     -KKWYVLQTYSGHENKVKTnlEDQIFSVKIPSMEVAEMKNGKKKVTKKKLMPGYVLVEMNMTDDLRFKIQNLPSVSTFVGGKGkpEPLSLDEIKNLFSDVGNVESEEVsfKVGETLKIIDGPFANFTGLVDEIFPDkrLRVRVEIFGRSTPVELDYLQVK--    
117 UniRef50_C0W699        Transcription antiterminati...   125     5e-28  1  23.8%   3:162  63:263     --EWYVLHTYSGYERRVAAdlEDYVFDAVVPMETVIEVKsgKKKEVSRVRIPGYVFVRMDLDdrVWRTIKDTPAVTGFVGDRYNPVPLTFDEAVSQLGpvEGGQVYEVAFEVGESVIVTDGPFESLPATISEIHPeqKLQVLISLFGRDTPAELSFTQVAKI    
118 UniRef50_A6GCJ0        Transcription antiterminati...   124     9e-28  1  19.4%   7:161   1:172     ------MNTFSGYENTVKKSLEDRIkdILVPSEQVIEQRGKRQVKQTRKFFPGYIFVRMRLTKPAWHLVKNTPKVSGFLSSGKTPKPVSQREMDRMLGKTEPKQVTEedYSVGDQVRVKSGAFANFSGEVEEVNTEKriKLSVSIFGRPTRVEVDFSEVEP-    
119 UniRef50_B1VAN1        Transcription antiterminati...   124     1e-27  1  18.8%   3:162  30:203     --RWYIAQTYLGYENTVKQDLLRriSNVLSPRETYYETrdGKKTSKERNLYPGYVFIEMIITDHSWFVVKNTPRITGFLGSSgkPIPLSEKEINPVLFKMGIMSKPNYDHLIGKKVEIISGSLANQQAKVSIIddREKIIVEVDLFGRTVPVEISFSDFKEI    
120 UniRef50_Q5QWY1        Transcription antiterminato...   123     2e-27  1  35.0%   4:160   9:163     ---WYIVRTKPKQEERAILNLENQGFGVFAPELTVKKVRRGVRTSVVERMFPGYVFVKPDDIIEQFYKLRSTYGVAGVLRFGDNIPKVPQRWIDQMRGV--DQLTDEQAPQIGDTVEIQQGPFRGFLAKIVKLDGESRCFVMLEWMQKEVKANFSYKELQ--    
121 UniRef50_UPI0000E0F5F6 transcriptional activator R...   122     3e-27  1  38.8%   2:161  15:174     -KVWYLLYCKAKEEGRAVMHLANQGIDAFYPKANITKVLRGKRQTVEEALFPNYVFAQLDHDVHNFTSVRSTRGVIGFVKQGKDYQKVSQALIDVFVQCDTVDKLDSALPTKGDNVMLQHPQYQNIPAIYQEPKGENRAILLIHLLNKPVELVVDNSQFTK-    
122 UniRef50_C4V5M2        Transcription antiterminati...   122     4e-27  1  19.6%   2:159  16:182     -RAWYVIHTYSGYENKVKANLErmIFDVVVPVENEIEVKDGKEKVVPRKVFPGYVLVDMIVDEHSWYVVRNTTGVTGFVGSEKHPIPLTAEEAERILssVGAEPKRRTKVNVGDTVRITSGAFEDYAGKITSIdsSMGVKVDVD--GKSLDVEIDQVEL---    
123 UniRef50_C6Y0K9        NGN domain protein n=1 Tax=...   122     5e-27  1  21.7%   2:162   8:167     -KNWYVVVTYPNLERKALLNLLKNNFIAFLPLQKVQRKWSDRKKTIEIPLFPNYLFINI--NEKDRFEALDIYGVKRYVTFGGRPAFISETDILNIKRIVESVDLyeHSLVKGDAVKIIGGPFKDMIGILFKKSGQARFGIRVESMNQTLSIEICHTLIRKV    
124 UniRef50_Q7UMY8        Transcription antiterminati...   120     2e-26  1  18.6%   2:162  48:225     -MDWYILKVAFNREDSIAEALRKKVrdIVVPSEDvtFTRDGKRRVSKRKLLPGYIMVYMSINDDTWFLVREVGGISDFTGSAGKPQPMEPEDVERFINRPAVDDEDEtpFKVGDRVRVKEGNFENQEGEVDVVDenGRVTVIINIFGRSVPMELDHWQVEPL    
125 UniRef50_C6QI43        NusG antitermination factor...   120     2e-26  1  23.1%   4:159  15:172     ---WVVVNAQAHREFVAASNLKKQGYEIYAPVIRKTTRHARISRESLTPLFPGYLFARWTAPDMRWRPILSTVGIRSIVRNGNEPSRLDGAIVDALKAREKDgvRAESQREIGQIVRFARGPFDGIAAEIVELCDKDRLVVLMTLLNRPTKVTVLEDQL---    
126 UniRef50_A6FES1        Putative transcriptional ac...   119     3e-26  1  40.3%   2:160   6:167     -KDWYLLYCKGKEEPRALINLKNQGIESFYPTMTVEKKLRNKLICQEIAIFPNYLFVAIDKNTANFNSIRSTRGVIDFVKCGANYTKVPAALVTELrrCRDKSANEVTVFSEGETVIIQDGAFKGIEAIYQCKDGLERSMLLINLINHSTTMSVANGEIK--    
127 UniRef50_Q01TC5        NusG antitermination factor...   119     3e-26  1  23.8%   3:162  18:177     --QWFALSVTPKLTQLVLMALEHKGYECFTPLQSSTRKRRDQVADMQVPAFPGYVFARIDV--RFRLPVLVTPGVRGIVGYGRQPAPVDDGEIFALRRVMQSQLPAkpYLRTGDRVQLVEGPLSGLTGLLIQQKGANRVLVQVTLINQALAVDVESAWVRSL    
128 UniRef50_Q2S1Q0        Transcription antiterminati...   119     4e-26  1  15.3%   4:160  10:182     ---WYVLRTFSNHEKKVRRYLedQVEEILIPTETVFEMKGGEKKTKEKTFFPGYILLNCTLTSDLRDLAEDLPSVIGFlgTGDEPTQLREEEIKRILGKMDrgEQPEMPFKVGDPVKVVDGPFDSFNGIVEDVYPDqkVKVMVSIFGRKTPVELDYLQVE--    
129 UniRef50_C8VZE8        Transcription antiterminati...   119     4e-26  1  13.8%   2:161   1:163     -MHWYVIHCLTGHEEDVRSRVKEKDirAVVPRRLMVERRQGGWQYVERVVFPGYVFVQAHMTPAAYYAMRNLPGVIRVLG-TSRPVPLMGNEVTLFLKLCRDGDplSEVFVKGGSVKVISGPLMGLEGHIVKLDARrrAKVNISLMGEPRIVELAVSVIKK-    
130 UniRef50_C7PUF8        Transcription antiterminati...   118     6e-26  1  16.9%   3:162  20:195     --KWYVLRVVSGKEKKVKEYLdnVITQIFLPVEKVYKVQAGKKVMREKNFYPGYVMIEAimTDEVIQSIRNVSGVIHFLG-KDKPIALRKAEVNKMLGKVDegLTMSEPFIVGETIKIIDGPFNDFNGIIEeiEDKKKLKVTVKIFGRATPVELNFMQVEKI    
131 UniRef50_C9RQP0        Transcription antiterminati...   118     6e-26  1  21.4%   2:160   3:175     -MQWYAVHTFTGQENNIKKRLEQMIEriIVPTREVVSNVRGKRRISVQNLFPAYIIIEMELDELTQHLVSTINGVTHFGGMTRapIPLRQSEVDRLLGVDPeeGEIQIPYTIGENVCIKEGPFKGFVGVVDEI-MEAKIKVMVSVFGRSTPVELAFNQVE--    
132 UniRef50_Q1Q133        Transcription antiterminati...   118     7e-26  1  19.3%   2:162   3:182     -KEWFVLRVQSNREDKVRDNLVERIrnVLVPSEKISEVKGGKKRVSDRKIYPGYIMVEIEVDeeVWFTIRETSGTGEFIGGQSKPVPMTKYEVEKLLsqKEERPRAKIEFNEGEKVRIKEGPFENYDGIVEEVLpsGRVKVMLTVFGRATPVELEYWQVESI    
133 UniRef50_Q04WD1        Transcription antiterminato...   117     1e-25  1  22.2%   3:160   9:170     --EWYALYTNPRAEKKLKRLLQERKIECFLPLISKKKKWSDRWKVVEEPMYPSYIFVKISFFQD-RVKILQLPGAHHFVFYSGKPYVIPDEDLNLIRIFLEtqVEIQERLLPGKKILIQEGPFAGFKAEIIQRKNEKQIIVKFPGMNLMTSVTLDIKTLK--    
134 UniRef50_A4EGG1        Transcriptional antitermina...   117     1e-25  1  27.8%   4:161  10:170     ---WFVLQLKPNGLSLARTHLARQGFLTLMPLREVSQHARYGLRTVRQPLFPGYLFFSVTARQINWPAAANTRGVTRivGTDGQPARLPADIAAGLLAITTEDGmdVADLQTGDQVGVVNGPFAGWMAKVVSADTPDRIQLLVDVMGRETAVNIAGRDLEK-    
135 UniRef50_C7NC81        Transcription antiterminati...   117     1e-25  1  24.2%   2:162  16:205     -KKWYIIHTYSGYEKKVAADLEKRifRILVPEEEVLEEKRGKQVKVSRKLFPSYVMIEmrVDSDAWYVIRNTNGVTGFVGVGSDPIPLSDEEASNLLAKIGIDVEGEtdFKVGEVVEVKGGSFDGQQGEIAEIdeHGKVKVMLEVLGRLTPVEVEHTEIAKI    
136 UniRef50_Q982S4        Transcription antiterminati...   117     1e-25  1  21.2%   3:162  13:181     --RWYVLRVEDRADIAVDKLLGEANVERVMLHTECEAKRRGRRKhvRVPSFPGYIFVKVVSCAATWAGLRTVSGVLGPIGGCDGPSPVSEQEILKFQARIENDPEatNALKAGDKVSIDSGPFAGFEAVVLMLGDKHKVHVEVDIFGRKTPIGFALAEVTKL    
137 UniRef50_A1VS68        NusG antitermination factor...   117     2e-25  1  21.2%   4:159  23:181     ---WFLAHTRPRLETVALQNLQQQGFDVYLPLYKRLKKIDAGMQAVFEPMFSRYVFFRTTSLAQSIAPVRSTRGVAQIVSFGSEFATIRPDMLDAIRQLEqaDVAELSTLRPGHLVRFCNSALSGLEGVVKSVS-SCRVAVLLEIMGRQQLVRVDHHQL---    
138 UniRef50_Q3AU98        Transcription antiterminati...   116     2e-25  1  20.6%   3:162   9:170     --NWYAVYVRSRYEKKVYQALLEREVNSFLPLYETIRQWSDRKKKVSEPLFRGYVFVNIAMQQESI-KVLDTEGVVKFIGIGRKPSVIAEREIEWLKKLVREPerTVASLPAGQKVRVIAGPFKDMEGVVVKEGRESQIVIYFDSIMQGVEVSIYPDLLQPI    
139 UniRef50_B0VGC6        Transcription antiterminati...   116     2e-25  1  18.9%   2:160   1:173     -MKWYVIHTYSGHENKVKTalEKQVGRLLVPVRKTFVIREGKKIERDKKLFTSYVIMEADMTPELKTYILQIAGVTSFLgeHKEPIPLSQEEVDRLLGITdnRDIKVYSYMPGDMVKVISGPFTDFEGIVQKTTENgkLIIEVTVFGRRTPVELNASQVE--    
140 UniRef50_B3ETZ5        Transcription antiterminati...   116     2e-25  1  19.4%   3:162   6:185     --KWYVLKVVSGQEKFVkrKLQDYVAQILIPSEKIYEMRAGKRQTRERNFFPGYLILHADLSdrVLHTIKDIPNALGFLgsSSQPIPLREKEINKILGRVDEIAEdeKPFIVGETVKIVDGPFSGFTGNIQEveERKKLNVIVKIFERNTPIELTYTQVEKI    
141 UniRef50_A5TS63        Transcription antiterminati...   116     2e-25  1  21.0%   1:162   6:193     VRKWFMIHTYSGYEKKVKTDLEQkvTNILVPEEELTEIVRGKPKKIYRKLFPAYVMLEMEATREewYEVRNTNGVTGFVGVGSDPIPMEEEEVKNIFNIIgpKETIKIDFAEGDYVKILKGSFKDQEGQVAEIdeHGRVKVMVDIFGRMTPVEIEVDGVLKV    
142 UniRef50_C6XVK8        NGN domain protein n=1 Tax=...   116     2e-25  1  21.6%   1:162  10:172     IKKWYPVYTQSRAEKKAYQALLSKGIEAYLPLQRQLRQWSDRKKWVEEPLIKSYLFVHIARQQQT--EVLMTTGISRFIYFSGKIAAMPDRQIEELKLLLASpeITEERLLPGEKIEIKAGPLKGIRGEIIEYRSQKQLLLRLGDISHSIVVNVSASLIERM    
143 UniRef50_A3V684        Transcriptional activator R...   116     2e-25  1  27.2%   4:161  10:168     ---WHIAQLRPNGLLMALRNLERQSVAHFAPTELRTERRGAKFVTRDVPAFPGYVFVQPSAASGGVRAVNSTRGITKLVTLGQGPAIVPAGLIAALRIRFAPPDITppQFDQGDWVRILDGPFAEFVAQVEATPAAERVYLLIDLMGRATRVAVDARSLKR-    
144 UniRef50_C0QI35        Transcriptional antitermina...   116     3e-25  1  20.8%   2:160   5:167     -KSWYTLLTKSRFENVVFNDIQKKSIEVFLPKIKKRSQRKDRKLMIDVPLFPGYLFVNITLDPVTHLSVVKTTGAVRLLGYSSGPVPVPSAHIESLKIVTGTGLDVvnTLQKGERVLVVRGPFSGVKGEFLRHKGKDRVIIKIETLGQFAGVEIDREDLE--    
145 UniRef50_B4S8Z4        NusG antitermination factor...   115     4e-25  1  19.5%   4:162   9:169     ---WYAVYVRSRFEKKVHLLLQEKGIVSFLPLVDTWRQWSDRKKKVSMPLFRGYVFVRIHYRQDHPF-VLDTDGVVKFIGIGRAASVIRDRDIEWIKILTGEPDVRKEvlPPGKQVKVIAGPFVGLEGVVRKDGRESKLVVYFESIMQGIEVTINAEYLSPL    
146 UniRef50_Q1ITB0        Transcription antiterminati...   115     4e-25  1  20.0%   3:162  13:172     --HWFAVQTRHRHEKRVAERLRQSEIETFLPIHRAVHRwnGINAEVNLPLFPGYLFTRLRGSQRI--PLLREPGVIAIAASSNSPTPIGDNEIAQLRLVAESVKAEPHPfaIGQQVKVVAGPLFGMEGILIRKKSEYRVVVSVKIIMRSVAVDVSELEIEPV    
147 UniRef50_Q1D5E3        NusG-like protein n=2 Tax=M...   115     5e-25  1  19.4%   3:162  10:166     --DWVALLVRVNHEKVAAAQLGKHGYEFFLPTYTPPKSSGVKAKL---PLFPGYLFCR--YQPLNPYRIVRAPGVIRLLGGDAGPEAVPAQELEAIRRVADSGVSSNPclRVGQRVRIIEGPLTGLEGSLVTSKSQLRFIVSVGLLQRSVSVEVSAEQLEPI    
148 UniRef50_O83264        Transcription antiterminati...   115     5e-25  1  20.5%   2:162   3:185     -KEWYILHTFSGREARVERAVrnVIFDIKIPEELLTEVKDGKKRVVRRKFFPGYLLVEMDLPEVDWreVRRIPGVSGFLGSSgkPQAVSADEARRILQKAGEipRIAQTFLVGQQVRIVEGPFATFSGEVEEvsERNKVRVAVTIFGRATPVELELVQVEAL    
149 UniRef50_C6PET8        Transcription antiterminati...   115     6e-25  1  18.6%   2:162   5:175     -EKWYVIYTRTGDELKVKRLIekKPIRVLIPKRAIIERKGKKRVEKIKFLFPGYVFIKTNMCFEIYYEISKLPHFLKFLKDEMEPAEVRDDEIRIILSLVGDSDifSTGIKIGGKVKIIDGPLKGFEGLIEKIDKRkrVKVRLNVSGNANLVDLGIHIVEKI    
150 UniRef50_C5EKF0        Predicted protein n=1 Tax=C...   115     7e-25  1  15.4%   1:162   1:170     MERWYAVQVRTGREEAVLQLSKKMikECFIPYYERMKRYQGEWHKEQYILFPGYIFLVTEQVDELFWELKKVPGLTKILGDGMEFVPIKEEEKVILQKMGGSDHIAEMsyVIGDIVTVISGPMKEMKGKIKFIDRHKRLAveIEMFGRKTEVRLGLEIVMKL    
151 UniRef50_Q5GRY4        Transcription antiterminati...   115     7e-25  1  17.4%   2:162  99:276     -YKWYILRVASNYEEKVCQHVLENSmeVFIPYEELSEVerSKKAAMRRKCFPGYVFLYVDLCDEVLNFVNNIPkvYGFLKNGSVPKVISDDEIYSMCNAlqETKKLSHGYEKGEKVKINDGLFQNFTGKVDMINDEKKIiiEVSILGKPTIIELDLAQVEKI    
152 UniRef50_C8WL22        NusG antitermination factor...   115     7e-25  1  16.1%   1:161   1:170     MALWYVVQTVGGQEKHVLDLieELIQESFIPQYEVKKRIQGVWKMRSEVLLPGYIFVITDQPGKLREALRSVPKFTRLLGNNDVFTPLDDQEVAFINAFTKPDHRVVEfvMEGDEIVILNGPLMNQTGLIKKLDRHKRLalEIEILGRVKTVKVGLEIVRK-    
153 UniRef50_C7PTI0        NusG antitermination factor...   114     1e-24  1  20.6%   3:162  14:173     --KWYVLYTYPLFEKKIGRQLALIDIIHYLPVKTEVRKWSDRLKRMEVPLFPNYIFVKTNLLNKT--PILGIPGVVRFVSVEGRAIAISEDDINKIRQIEQsdVEIESVYNTGDKIRILNGVFSGLEGELYKRSNRLRVLIKLPVIAQAVSVEISNCDIEKI    
154 UniRef50_C7PGB9        NusG antitermination factor...   114     1e-24  1  21.2%   4:159   8:163     ---WYAVYTKPRWEKKVADALVRKQIETYCPINRVTHQWSDRKKIVEEPLFKSYVFVRIP--EDKKTLVRETSGIVNFVYWLGKPASIPDHEVELIKRFlqDVQVERFPIQEDDLIRITAGPLMHQHGRVVEA-GKNTVKAVLYSMGFSLIATVKTSDL---    
155 UniRef50_Q8R8A2        Transcription antiterminati...   114     1e-24  1  23.3%   4:162  16:178     ---WYVVFTYHNAEKRVEEHINSliIKAEVPVQKRTVSRRGKIKEIEEKIFPGYVFVKAVMTPEVMAAIRRINGVAHFVGGGNEPVPITPEEVKRARIQDDLSEE----FKAGDTVMITDGPFENFIGKIIKIEGRK-INIALSLFDREMGIDFSPEQIMKI    
156 UniRef50_Q2CAE9        Transcriptional antitermina...   114     1e-24  1  28.8%   6:161   1:161     -----MAQIKPNGLRLATQNLARQGLAVFCPLQQASRRIRGQIRSVTKPVFPGYLFVSLAPAGGEMRAASYTRGVARLVtdESGPKAVPDALIEELQARCTPepPEADQLDVGDRVWVTDGPLAGQVSRIIALAPEARIWLLLDLMGRQTRVAVKREAVRR-    
157 UniRef50_B9KHV6        Transcription antiterminati...   113     2e-24  1  16.2%   3:162  11:186     --EWYIVQVSSGSEEKVAQMILERSqeVFIPYEEVTKVKYNKKVAMRRKLSPGYVFLYMRLSDDAINFVRRVPKVSNFLLDdgLPKVIPASEMETMRSSmsEAASEVCSFEVGDEVVINDGLFQDFNGRVEYVNEDKKVavSVMIFGRLTKIEFKLSSIQKV    
158 UniRef50_A3XR75        NusG antitermination factor...   113     3e-24  1  23.4%   2:155   1:154     -MNWYVLYVKPQSEKKVASALEKLGVKVFCPTLEEVRVWSDRKKKIQVPLFKSYVFVCLPNTE--RQQVFAVPGVVRYLFWLGKPAVVRDEEIAAIQDWLSDedVQVRTYTPGTEVKIAAGHFKGQKGIVQEV-GRKRLKMVIKSLGVIVEARLK-------    
159 UniRef50_O51355        Transcription antiterminati...   113     3e-24  1  16.1%   2:162   3:184     -RAWYVVQTYSQYEKKIEQDIRLLilDVKAPIEKVEEIRNGKKRIRERKIWPGYILIELDLPEVGwaNIIKVQGVINFVGvgQRPIPINDEEVKSVFMLTGEIKANkyDFEEGERVRIKGGPFDSFEGLISSIdeRKKLKVAVQIFGRSTPVEVDFQHIEKI    
160 UniRef50_B0A697        Transcription antiterminati...   113     3e-24  1  15.0%   3:162   8:179     --KWYVVHTYSGHENKVKATIEnyIKQVIVPTEDVIEtkTGKEKVRQRKIYPSYVLIQMIITDESWYIVRNTKGVTGFVGPGSKPVPLSEEEVKSMGIDLDKIGEKRTEIEVGEVVNVRDGVFKGQSGVVKELdkNEKVKISvnGTSGELSLELDLKSIETI    
161 UniRef50_B5YJ95        Transcription termination f...   112     5e-24  1  17.7%   3:160   7:167     --NWYCIYVKSRHEFKVFDRLTKAGIEAFLPAVERLRRWKDRKKLIKFPLFPGYLFVCIEKSYELMLKVLKTPGVVTFIksGEPEPIPEEEIVPLRKAIENGREIDppYLKEGQRVKIKSGPLAGATGILKKKEKQHFFIISIHILQRAVSVKIDASEVE--    
162 UniRef50_UPI000197AEF0 hypothetical protein BACCOP...   112     5e-24  1  15.1%   2:160   4:166     -ENWYAMYVRMHHEKKVAEKLGQMGVEHYLPVQEVVRQWSDRRKKLQVVVIPMMIFIRAS-EQVRLSVMRNIPSVSGClrCTHRPAVIRDEEMQRFRFMLDYSEEAVHFInpGQKIRVIKGPLAGLDGELTEIDGKSQVMVRIEQLGYA-SVEMPVGYVE--    
163 UniRef50_Q1NMQ2        NGN n=3 Tax=delta proteobac...   112     5e-24  1  24.4%   4:159  10:171     ---WYAIRTKPHKEEMARQHYLNQQYTVYLPLMRVVRSHARRRQVVFRPVFPGYLFLRLNPETCDWAAIHATRGSIGPLRFGEHYVPVPDWVIEGLQAREDEEGvqKEKLVPGCEVEVTMADGSAGKGFFCSFRGKENVEILMDILKRQVRTTVPLDRV---    
164 UniRef50_C8WIE4        Transcription antiterminati...   111     7e-24  1  19.0%   4:161   2:168     ---WYVAQVQAGRESSTLEMCRRLveDCFMPEYEVMWKIRGEWRLVKRLLFPGYLFFVTDDPEALNRELSRVPMPIRLLGNEesFFPLTGKERDWFLSFMDGNhrMSEGYISGDKITVTRGPLMGFEGDIRKIDRHkrAYIDVSLFGRTVPASVGLEIVRK-    
165 UniRef50_A6EBM5        Putative uncharacterized pr...   110     1e-23  1  19.5%   1:159   8:167     IKKWYPVCTQSRAEKKAYSELTRKNITSYLPLQRQMKQWSDRKKWVEEPLIRSYLFVHISRQQQ--AEVLMTSGIARFIYFSGHIASMPEQQIEQLKLLTASpeITENNLLEGEKITIKAGPLQGMSGEVVAYRSQKKLLVRMTELNHAILVHIPASLI---    
166 UniRef50_Q1IKV1        Transcription antiterminati...   110     1e-23  1  20.4%   3:159  26:182     --SWSALFTYPRHEKKVAEQLLCRGVESFLPLYAEKRTWKNRQTVTLtpLFPGYVFARFARRDRVR--VMSLPGVVSIVERAGAVSSISDHYIEKLRAGIRLGRVRPFREAigDRVQITSGPLSGLEGVLMHFRSEFRVVVSIGMIGQSVSIEVLRDEI---    
167 UniRef50_C7PS65        NusG antitermination factor...   110     1e-23  1  20.8%   4:162   8:169     ---WYALYTMPRHEKKLHTRLSELNVTSFLPMTRMLRTWHDRKKYVEMPLFPSYIFVYLN-NIEHYYNVLNTNGALYYVKTGNELSRISEQIIHYIRIVSEQseLSADYFPPGKELLISSGPLAGFSCEVVSYKNSEKILVRVSLLQRSLLCSYTADSleKL    
168 UniRef50_Q6AIA2        Related to transcriptional ...   110     2e-23  1  24.1%   3:160  28:191     --HWYAIRTKNKKEEVAKFNYQRQGYTVYLPLLRKTVHHARSTTEKLVAFFPGYLFLNLAPAEQNWTAIASTRGSLGALCFGDSYIEIPGWVISDLKAREDKgdLIKENLTPGSVVTVNIPGLESVEAVVYSIRGSENVDVLLNILSRQVKTTVSLDRIK--    
169 UniRef50_A9ECY4        Putative uncharacterized pr...   110     3e-23  1  20.0%   2:161  27:187     -RNWFVLYTAPRAEKKAKLELEYRGYEVFLPMTKSLRIWKNrkKLIDSVLFPSYIFVKTD--ERYLAEICRINKIATYIHCGGKPCKVSPECIEAIKCMLSMDQEISvdFIEGESVRIVEGPLAGYNGVLVQQKSKTKFGIHLKEINQVASIEICTSALEK-    
170 UniRef50_A6L3Q7        Putative transcriptional re...   110     3e-23  1  14.8%   1:162   1:165     MKKWLVAYVRLHHEKKTAERLTAMNIENFLPVQEEIRQWTYRKKKIKRVVIPMMIFVHVDAAERSQVLTLSAISRYMVLHGEHTPAVIPDEQMERFKFMLDYSDEAVEmlAPGELIRVVKGPLKGLEGELVEVDGKAKVVVRLDLLGCA-GVDMPVGFVEKM    
171 UniRef50_Q5LEP1        Putative LPS-related regula...   109     3e-23  1  18.2%   4:157  15:169     ---WYAVYTAPRAEKKVKEQLDKIGVENYLPLQPVVRLWNNRKKKIFIPVVPGCLFVHISSEEIAH--VAGIHGVAFLLKEKGQYVSIPEVQMETFKTmcELVEFAPNEFVPGTVVRVISGQLQGLEAELVECQGNNKLLLRVEGLGCAL-VTVSTD-----    
172 UniRef50_C7PT75        NusG antitermination factor...   109     3e-23  1  20.3%   4:161   8:167     ---WYLLYTRPRQEARVAKEMADKNIQIYLPYTTVTRRWTDRIKVLEVPLFPSYVFVHLT-NMHEFYYGSNLESACSYVRFGNEVARVSDAAVDAVRTIAKAgeVSSERFTPGQQMMIKEGPLCGLNCEVIQYKGKDKILVRVHMLQRSIMADMPASVLIP-    
173 UniRef50_B9XAW5        NusG antitermination factor...   108     5e-23  1  26.9%   4:159  34:192     ---WYCVRSKPKHEHIAAANLSkqVVETFNPSLRSRKATRRGPVWMTESLFPNYIFARFPF-EQMFDEVKYTRGVSSLVHFGTGYPEVPADVIEELRrpANELKLSSEVPTAGDQVTITSRALFGLQGVVLrmPAQRRVQVLLDMLGQTSAVELNLNSV---    
174 UniRef50_D2QI92        NusG antitermination factor...   108     6e-23  1  23.1%   2:161   1:160     -MPWYVLCTKPRKEKFLAKLLAEKQIEVYCPLIRRKRRWSDRIKTVEEPLFPCYCFVNVKESERADVFV--TPGIVRYLYWLGKPAIVKDKEIDLilNQFDHDLIHLESFNPKDKVVINSGSFMGQGGTVVNQQG-IKVLIHLDSLQLCIRVDTSKTLIAK-    
175 UniRef50_C8WIA3        NusG antitermination factor...   108     1e-22  1  16.5%   4:161   2:168     ---WYVVQTVAGREFAVCRLIESLvqECFVPRYEVQKQFRGQWRTCTATLFPGYLIVVTDRVDELESQLRRVPAFAWVLSNDGGFVPLERDEVAWIDAFTEKGHRTveGVIEGDRIIVLKGPLVGREGWIRKINRRKRTalEIDMFGRTIQTKIGLGIVRK-    
176 UniRef50_A5FN19        Transcription antiterminati...   107     1e-22  1  22.4%   2:153   1:152     -MNWYVVYTKPKWEKKVAEKLTQIGIECYCPLITQVKQWSDRKKKVEMPLFNSYVFIQI--EDADRNSVFEVAGIVRYLFWLGKPAVVRDEEINVIKNSLKAsdISVSQIQVGDKIKLETGAFSNQNAIVQEVSKTHYILV-LESLGCVLKIK---------    
177 UniRef50_B5Y935        Transcription antiterminati...   107     1e-22  1  19.9%   1:161   1:180     MKKWYIVTTVHGKESAVAEAIKLriSDVLVPKEWRLEYRGKKPrrVQRVIYPGYVFVEVeiDPETWSLIRYTPGVRGFIStdHTPIPVQDNEMEKVLQKSREQEAVKVDLQTGDEVEVRDGALKGLTGVVVDVDHEkkVFVKISMFGREVISDLDAVQVRK-    
178 UniRef50_C8PLY0        Transcription antiterminati...   107     1e-22  1  16.2%   2:161   1:170     -MDYYAVQVKTGKEPELLKKieNHEIQAYFPRRVLYIKKKGIRQKVDAPVFPGYIFLEIDDLSLPLcqLRKTPNFYHFLPNNQNPLPLVDNDLSLLHHFLSFGepSKVYFDANSRICVIDGALKGLEGKIIKVDRRkrAKVLLDMYTDSFPIDLAFDVIEP-    
179 UniRef50_C3RLT4        NusG antitermination factor...   107     2e-22  1  16.9%   2:161   3:171     -ENWYVIQVRTGKEEKIKNTCEKLIseCFIPKCIRLKKYQGTWKEVDEVLFKGYVFMISDHIDELFNKLKLIPDLTKVLGNDGEFipILKEEAIFLLKFGKEKHIvsQGYIEGDKINIISGPLVGYEGMIKKIDRHKRVaiEVKLFDQITMVQVGLEIIGK-    
180 UniRef50_D2LJZ0        NusG antitermination factor...   106     2e-22  1  28.0%   3:159   8:166     --KWVVLTTHPHRENFAVENLARQDFTAYCPMTVKHVRHARRAYDAPRPLFPGYVFVEHQSAFQYLRPILGTYGVRSILRIGDSPAVLPVGFIESLKAREMDGvkPEAPLKAGQTVTISGGPFDGLVGQILEFRERDRVLLLLDLLNQQTRVQVEAKML---    
181 UniRef50_A3I2H8        NusG antitermination factor...   106     2e-22  1  16.9%   3:162   5:165     --KWFVMYTASRSEKKVAKRLRENGKEVYLPIIEEIRQWSDRKKKVEKPLFNGYVFVKTTRNQLWECL--QVPGAVKFVHFSGQHATVRDEELETIERIISTGVAVESdiEAGEKVEVIGGALQHMTGEVIEKGNKDYFLIRIPSIYQNMLVSIPRKFLQSL    
182 UniRef50_UPI0001692BF2 putative transcription anti...   106     2e-22  1  17.1%   2:159   1:173     -MLWYVLFVTTGKEDVVGKYISnlSLQCFIPKKVVPECHKGVRRDVIRVLFPGYIFIRTTMSSNLYYLLKEIPNLHYLVNSGDrySAIPEEEMEWIRDLTGNRDTIEYSeiINKKVKVISGPLKGKEAMIKKVDKRkrAKIEVTLLNKTNLVDVGINIL---    
183 UniRef50_UPI0001B49F58 putative LPS-related regula...   106     2e-22  1  18.1%   4:147  15:160     ---WYAVYTAPRAEKKVKEQLDKIGIDNYLPLQPVIRMWNNRKKKIFIPVVPGCLFVYISSEEI--AQITSIHGVAFLLKEKGQYVSIPEVQMETFRTMIERSHELVEffVPGSTVQVIRGQLQGLVAELVECQGNNKLLLRIEGLG---------------    
184 UniRef50_A3J1W0        Putative transcriptional re...   106     2e-22  1  25.7%   2:153   1:153     -MNWYALYTKPRNEQKVAQKLQALGIIAYCPLVLSSKQWSDRKKKVLVPLLPSYVFVQI--EEQNRKDVFQVGGVVQYVFWLGKPAIIKPNEIEALKQQLDSSIPVVHfwRSNETIQITEGVFKGQDAIVDKISTNK-VRLLLKSLNMYITIE---------    
185 UniRef50_A9DI26        NusG antitermination factor...   106     3e-22  1  20.3%   4:161   7:168     ---WHVLYVKSRWEKKVHNSLENISIKSFLPKTKTVQQWSDRKKTILTPLFPSYVFVYIE-SPLDFHKALSVDGACCYIRFGKEYARVTEKEINQIKLLVDSKEinPTFPKIGEMKKIEQGPLSGLDCEIIEAENYNKIIVRISSLRQNILATIPLNSFKK-    
186 UniRef50_B3DWJ1        Transcriptional activator R...   106     4e-22  1  27.6%   4:159  11:168     ---WYCLSIQPKKEKLAVENLKKENIEVFFPQFQYQKIRSRKTSLVLEPLFPGYLFAKFNLYSKLTF-VRSTKGVRKVVHFGSSYPVIPDSFIEELRIQFGEekTIRERIDVGSTINIAEGPFQGYSCIVLgiPAKERVRVLLEWLGRAVQIEVNLKEI---    
187 UniRef50_C4XFX3        Putative uncharacterized pr...   105     5e-22  1  16.5%   3:160  10:200     --QWYMISTVSGKEDKVVEALKNRIidCftPKELEKQKNGEEYKVKYVNMYSGYIFINMDMTDRAWFIVRNTQYVTGLIGSSgkPTPVSQHQIDkiKLQEDFDkvTHTKFQIGEIVEIIDGPFKGEQGRVLECSenKKVTVEIEYLGKKTPADFEYKEIK--    
188 UniRef50_A7AFP3        Putative uncharacterized pr...   105     5e-22  1  20.3%   3:155  24:171     --SWYVLYTAPRAEKQVRDRINALGVECWLPLHRAPRVWSDRVKIVELPLFNSYLFVRCTDPEL--RNLTRVYGVARIVYYNGKPAVVRQKEIDAIQDFLD--QASEHALCPGEEVEILCGAMKHVSGKVKKIKKNH-LVLYLEQLGATVCVKLD-------    
189 UniRef50_B4D2H1        Transcription antiterminati...   105     5e-22  1  25.2%   3:161  19:180     --KWYCLRAQPKHEHIAAARLRqeEIQVFCPRVRIQRSTRRGLVWFTEALFPNYLFARFEWVQ-SHALVRSCQGVSGIVRFGDHVPEVPAGTLDDLRAYMEDAELKTVSFneGDDVEIVEGPFRGQNGVVKQLLprERVKVLLEVLGGATEVDLCLTSVFK-    
190 UniRef50_Q1QKQ8        Transcription antiterminati...   105     5e-22  1  20.4%   4:160   7:192     ---WYVLQTRPAHEDKAARGLVARGFDPYAPVVYRrrDDKGRkrEIARPMFPGYIFVQFDAGDEKFAEVRIVPGITGYLKDegEPQAVPDVAMDLIAVSETEekRGPPEFKAGDDVRVVRGEWKDWIMKVSKADDLGRVVLLFHIFGRETKIHADQADLE--    
191 UniRef50_Q2ST07        Transcription antiterminati...   105     6e-22  1  16.2%   3:162  19:211     --QWFVISCQTGHEEKVLGDLQQKIkeVFSIKISKANQVSKSGKASIKNKFPGYIFINMIMSEKAWFLIRNTPGVTGFIGSSgkPSPLTIEETLNMLVPNIEEIQQAhdFKIGDIVKVKSGIHENEEGTVKDMDYSKGVavAIEMFGRWTTLEVSFKNVEPI    
192 UniRef50_B9YBP8        Putative uncharacterized pr...   105     7e-22  1  23.0%   2:162   1:170     -MNWYVLFVRGGMEEKIRDFFLSQGLNAFIPKMKVVFRKQGISELVEKIMFPGYLFIESemDEQIKELRMQKTGIVKLLKFDKEGTplRSEEKDYLERLLGKNKVLEHslIQGNQVIITEGPLQGFESQIVKIDRHkrAVLELELCGQPRRVSVSLEIVQKI    
193 UniRef50_Q3SSD1        Transcription antiterminati...   105     7e-22  1  21.2%   2:161  33:210     -KYWFILRTHPGCERKVMREFERRNISAYCPLirVVRRVHgiKRLVQVPLFPQLVFV-----PDFERVPADIGGVSGWLRFGGWRARIPSedIHALVAIANTPQSKRarFEIGALVRIVDGPFRDFSGRIERLDSKGRLKVAIEIFGRLSPTEMSEAQIEP-    
194 UniRef50_C6LL07        Putative transcription anti...   104     9e-22  1  17.7%   4:161  17:182     ---WYVMQVQTGMEERICAQCRRKISecFIPRYEVKKHIQGEWKTQKQILFPGYVFVVTSDIQNLHEELKKVIGLTKLIGTGREIVPISENEKEFLLGfeEQVVQMSEGIITGSQVVIHSGPLKGKEGYIRKIDRHKraWLELPLLGGMQNVQVGLEIVCK-    
195 UniRef50_B8IE36        NusG antitermination factor...   104     9e-22  1  21.9%   5:159  37:193     ----YAASVAGHGEYRACEWLQQAGFATLAprTAVVRQASSGKRLVRRPVFPGYAFVG-KRPEQSWRDILRVPGVRALVTTGEAPTELPPWMMKMLIAamGAYDRPRPQLAVGDKVRIRDELWQGLIGEVMRAPEGRRIAVLLKAFGKKHVLSVDVDRL---    
196 UniRef50_B0P702        Putative uncharacterized pr...   104     1e-21  1  18.4%   1:158   1:163     MAKWYVLQVLAGQETAVRDALHIMGIRAAVPQEERLLRKNGGWTSRIYTLFPGYVFLSLEYSAENYYRVKAVPHVLRFLGFSgsPSCLTHLEAEWLRLLSNGGEPLKPSRvpDGSVRIMEGVLQNFPVRSIHFDRrrRARVGITLCGEPKILTLSMGS----    
197 UniRef50_C3MAS1        Putative uncharacterized pr...   104     1e-21  1  19.8%   1:162   1:168     MGHWYVVRTRAGQQQKATREFEDNGVTVYCPMLRRETRhsKKWLMKECPLFTGYVFAYLRISD--FGTLREMRHVLSVLAdgGTPIPVAGNIVEDIRDAQERGdpPVRRLKAGDTVQVKDGPLTGHYAAVTNIVGRRAIKAFVEIFGSLREVEIGLESIRRV    
198 UniRef50_C0ZGR2        Transcription antiterminati...   104     1e-21  1  16.9%   2:161   1:175     -MKWYAIFVESGKEEVVQKYLreQSLKSIVPKRLVPEKKSGIVYNVLKNFFPGYVLIQTEMTNEMFHKIKKIPRSLRLVNNGSYYSqiEEKEITPILQLMGNGEvySKVYLENSKVIVESGPLKGLEGIIKKVDKHkrAKIFLTFMGVEKTIDVGIEILSK-    
199 UniRef50_B8IIP1        Transcription antiterminati...   104     1e-21  1  19.4%   3:162  58:230     --RWHLVDCRAGKARQFADALAAGAIPALRLSEEVVRVRSGRPIRTRMPLFGRLLFVGLDpeDAHWLRDKYDREIKGVRFRDEKFMLVPGRELDQFTGVLGGDVPpvEDFEIGEAVRVADGPFASFSGLVEEIDAeqNLKVSVSIFGRSTPVTLEPTQVEKL    
200 UniRef50_C2NS75        Transcription antiterminati...   103     2e-21  1  19.5%   1:159   1:173     MksWYALCVRSGYEDLVerDLNETLVSVLVPKKTVPEKRKGHFKWVTRKLLPGYILINTSMDAKMYYKLKEIPNCYNFLndDIYFLEIPDQEITPIIQLLNDRGTIeeAYFEGSKVIVKSGPLKGREGIIRRIdrKKRAKLLLNFLGDTKMIDVGVEFL---    
201 UniRef50_O84322        Transcription antiterminati...   103     2e-21  1  17.3%   1:162   1:175     MFKWYVVQVFTAQEKKVKKSLEDfiQQIILPSENVMEVKKGEHKIVEKYIWPGYLLVKMHLTDESWSYVKKTQGVVEFLG-GGAPVALSEEEVKNILADLEEKkvQKHKFEVGSQVKINDGVFVNFVGVVSEvhDKGRLSVMVSIFGRETRvdLEFWQVEEV    
202 UniRef50_A6DRM3        Putative transcriptional ac...   103     2e-21  1  25.2%   3:161   5:166     --DWYCLYTKPRQENLTAQSALDAGFPTFNPKIEVRKVRRGKATYVHAALFPSYVFIQA--NEGNLDKARYLRGVNRIIGFggESLKIPAVILETLSTFLEDNVYKHDmlKDGDKVQVLDGPLKGVEAIFKklKDGERAVVLFELFSNYQEAKVNIEDLIK-    
203 UniRef50_O67757        Transcription antiterminati...   102     3e-21  1  16.0%  32:162 116:248     -------------------------------KITCKENKTEAKIVLDNKIFPGYILIKAHMNDKLLMAIEKTPHVFRPVMVGGKPVPLKEEEVQNILNQIKRgkPSKVEFEKGDQVRVIEGPFMNFTGTVEEVHPEKrlTVMISIFGRMTPVELDFDQVEKI    
204 UniRef50_B7AH17        Putative uncharacterized pr...   102     4e-21  1  18.1%   2:161   8:170     -RHWYAVYVRHNTEFRVESWLREQGIEIYLPVQDVYREHAGKRIKVTKPVISGMLFVCLSRPELT--IVEHAPNVHHFfrGTNAPLIIPDQQMADFRFMVDLSDTSILMVnpGTMVTVAKGSMQGIRGEMVKYESKYYIAVRLQELGCAL-VSVPVSYVRR-    
205 UniRef50_Q7D1F8        Transcription antiterminati...   102     4e-21  1  18.8%   3:162  14:188     --EWFVVETKHKAEKAVEDALRKAGVKVFLPLETitVVRGRIIPAVSRPLLPGYVLVNIVYSPAAVCGIARLEGVAGFVGGMVHPHRVSDEEMNRFKAFGDDETAPdeQFKRGDKVRFVLGPFASFGGNILKLRKDRAvvVAVDVFGKVSTIEAPLALLEQL    
206 UniRef50_Q4A951        Transcription antiterminati...   101     6e-21  1  14.2%   1:162   3:188     IYKWYMISTISSKEDTAISLLKNRIkeHfvPYYEENPNKPGEKKLKYRNLYKGYFFIKMNMVDKAWFVVRNTQYVTGLVGsgTKPTPISPRQFERMRKKWDQQILNFQqwEIGDWVKVTHGPFSDDFGKIIEMNVTKtiTVELevFGRRTPATFEYKNLKKV    
207 UniRef50_A6UA20        NusG antitermination factor...   101     6e-21  1  18.2%   4:162  52:219     ---WFALRVWTGREKTVEKSLDIMAVRSLVPMRKGPDLRRRGRViqMMPVIHGYVLVQMMALSEYLAGLLGVEHVIDVLGGCERPMRLSDKEVNRFNGLARNGNFDWERprAGEPVLITAGPFCDRRATVITPSKKGrvVVSIDFMGGEVPVTVPLALLKKL    
208 UniRef50_D1AXH4        NusG antitermination factor...   101     8e-21  1  18.6%   1:161   9:189     VKKWYIIHTYSGYEKKVKTDLEKRifRILVPEEKIFEEKKGKMVPVFRKIFPSYVLVEmrVDSRAWYIIRNTNGVTGFVGVGSDPLPMDEKEVEEIFSKMSNEDFQEkeYEVGDYVKTLDG----IEGTVEHIDyaKQIKIVIQVGSRPTTLTLGLNEVTK-    
209 UniRef50_A4YU22        Transcription antiterminati...   101     1e-20  1  14.5%   4:162  31:199     ---WYILRTHPHCEAKVMKAFRLRNISAYLPVMTvrRMRRgeRRDVVSPLILGAVLI--PDFEERWQCWRGVDGAVGLLRFGEWTPRLTPKLFQDIRKIEDIANTPKSkfEVGQLVRVLSGPFRYFSARVERIDSRGRLSVGAEIFGRITPIDIDEGEIEAV    
210 UniRef50_A7Z6E4        Transcription antiterminati...   100     1e-20  1  16.9%   2:161   1:175     -MKWYALFVESGKEETVQKFLreQALYSIIPKKKVTERKAGIKYEALKKMFPGYVLFKTKMTERTFHKIKELPISCRIVNNGAYytTIKDEEILPIIRLIGEGDtySKVYIENSKVTVASGPLKGMEGIIKKIDKRkrAKICLSFMGLDKMVNVGIEVLSK-    
211 UniRef50_B8IAM8        Transcription antiterminati...   100     1e-20  1  19.4%   2:161  90:254     -RRWHVMVAKPRFARRAAKDLTKAGIPAVLTDERVevEESGRRRIVKRPLLRRVLFVGLPRCAAPEVVHRETYFVRDAVRDggRAIQVPADQLRRFVRALADteRDPNAFEPGDEIRIKSGPFASFHGIIEDAdaTRRLKVAVEIFGRPSPVGLDFSEVER-    
212 UniRef50_C5CGE4        Transcription antiterminati...   100     2e-20  1  21.8%  44:162 226:353     -------------------------------------------KITRTRLYPGYIFIEMIMTDETWNLVKSTPNVVNFVSNGGQPIELKPKEIKALLRLVGLEekVEVDFEVNEMVRINSGPFEDFVGKITEIDPERqvKVVVSIFGRETPVMLNLSEIEKI    
213 UniRef50_B8I511        NusG antitermination factor...   100     2e-20  1  19.4%   3:162  16:187     --HWYVLFVKSGREHRVEQYLKKIviNPFIPLHEFLFKISGTVKRELKPLFPGYVFIESDMAGQEfnKIYLLSDIVRILKYSDTEIAVRDSEKQMLLDLCNNEHCIESsvIKGDRIYITNGPLRGRESIIKKVNRHKraLVEMEFMGDKRLVSVALEIVEKV    
214 UniRef50_A5CC98        Transcription antiterminati...   100     2e-20  1  18.0%   2:162   9:181     -YQWYIIRT-SGSESSIKQTILEKaeEIIIPGIQVVKMKRGKAINVNKKTMPGYILIKMDMIDQVKDFMQKVVKLNRFPGNESKIVQVTEKEVQEMMVQLENKAQDpeKYQIGEEVRVNDGPFETFVGRIEEVDYAKKikLSISIFQRSTELTVDFSQVEKL    
215 UniRef50_C4FB35        Putative uncharacterized pr...   100     3e-20  1  16.2%  14:161  13:169     -------------EDRAAALIAkaVDDCFVPKREVTHRKSGQWHRILEKLFPGYVFVRTSAPKQIREALGRVPAFTRMLTsgDTCLPLTADEVAWINAITNVDTHVMEmvIEGDCVMVIRGPLKGHEARITRIDRHKRLavDMDMFGRHKAIRVGLEIVSK-    
216 UniRef50_Q2RYZ3        Putative uncharacterized pr...    99     4e-20  1  19.7%   4:160 116:275     ---WRVFYTRARAEKKCETRLDERRIDVMVPKKTEVRQWSDRTKEITEPLFRNYLFARVDEKDRLR--VLRTNGIVRCVHFDGEPARLREETVDRLQKAQAVPERLStrPAVGETVTITGGplQGLTGKVLQHRGQTYLLVQVRAVRQAVKIEVAADWVQ--    
217 UniRef50_P29397        Transcription antiterminati...    99     4e-20  1  21.3%  36:162 217:352     -----------------------------------TRKEIRIYKTKRRKLFPGYVFVEMIMNDEAYNFVRSVPYVMGFVSSGGQPVPVKDREMRPILRLAGLEEYEEKkfKVGDMVKIISGPFEDFAGVIKEIDPERqlKVNVTIFGRETPVVLHVSEVEKI    
218 UniRef50_B5CXQ3        Putative uncharacterized pr...    98     8e-20  1  16.2%   3:162   8:171     --HWYAFYVRMHHEKKTAEKLEMLKVVHFLPIQEVIRQWSDRKKKIKQVVIPMLIFICTD-EKGRIELLQNLPSLTGClpATRRPAIIRNEEMEKFKFMLDFSDeqSEPLAPGEKVEVIKGSLKGLQGELVELEDHSQVMIRIEHLGYAT-VEIPVGYVKKL    
219 UniRef50_A8S2H9        Putative uncharacterized pr...    98     9e-20  1  14.8%   2:156   1:154     -MLWYVVQVRTGEEKDIAAKLTDMGFQTLAPVENRPVRSGGAWGTKEYVLFPGYVFLQMDYNAGNYYRLKAVPGIVKLLSGTLTY--LEAEWIRLLAGQGGRPLEPTLMRETEEGLEIETGILQNFKSRIIRMDKRsrATIELSICGEKKEVQLGI------    
220 UniRef50_B8IEU5        Putative uncharacterized pr...    97     2e-19  1  16.8%   2:162   5:170     -RTWHLVRTAPSMMGRALDTLKEQGIPTVVPRTVAVGHREGRPYLRRAQMFHRTVFVGVEGAADLDGKVPTARGVTRVLRNPTrpMTISGPDMAAFVAAIgtEKRKPAGIAAGDRVVVQAGPFASFPAMVEEVLPNERLKVAVQIFGRATPFECGHADVRPI    
221 UniRef50_B6GCE7        Putative uncharacterized pr...    97     2e-19  1  14.6%   4:161  37:203     ---WYVVNVPTGRESALCKVIERivRECFSPLYSTQIKRGGEWLDVEKTLLPGYVIVATEQIGRVKRLLREVPEYTRVLNMGESFVPLADGeiDAFTRKGERCVPMSMGVMEGDHVVVVSGPLLGREACIKSVNRHRSIavELEICGRRVTTKVGLGIVSR-    
222 UniRef50_D1PRH1        Putative transcription term...    97     2e-19  1  16.2%   5:158   4:163     ----YVLQVITGREKDICGRLRKAGIPAYCPRAVRQIRRGGRWQEQTYTLYPAYIFVQCERVVDVYYAVRREDGVLYWLGAtgTPEPLSADEEANILWLAGDGPQPVSkcRADGSLDFTSGPLkeLEALRSVFRRERRATAVLPLHGKEHKINLSFEI----    
223 UniRef50_B9JXL7        Transcription antiterminati...    97     2e-19  1  19.7%   3:159  51:218     --RWVVARCKSGLEQVIRDALAEQGIDCWCPCERRRLPPRRRKpvVERPLFRGYLFVRVIPDNEAYAGLLLASRLQSLMGQDGKPYLMPETLMRQlrRHMDAGDVPPMPDMLGKQVTIRSGPFADFVVTVRKvsKRGQVVVDVPMFGGMSEVTVGVEAI---    
224 UniRef50_A7FC44        Transcriptional activator n...    97     2e-19  1  37.9%   1:161   1:146     MKNWYLLSYKYGQVNRVQFGLDRLGVNSFSPSIQVKKVRsgTIRLVNEPMFPTYLFVEFDIESIHTTTISSTLGVNYFVKFGTEPKPIPLSLIHQLMNRSE----------------CSSQRNEEIDEIATIPDKKLRCALFIKLITQ-IPDSFEQNSLIK-    
225 UniRef50_Q48MX6        Transcriptional activator R...    95     5e-19  1  25.0%   2:149  42:187     -KEWYLVQCKSGQDSRAEENLTAQGYANFRPTINASSESRSVNTKHNSPLFPGYLFIHLSASD-NWAPVRSTKGILTIVKFGGRAHAVRNEIIQDIKTRAESLNYSHSSHSEKDSAPLDN-RGSEISDILSAKSHEERTLLLVGFLQRE-------------    
226 UniRef50_B0K4N5        Transcription antiterminati...    95     6e-19  1  17.5%   1:160   1:166     MKKWYVIFTRSGYENKVRDIIekEEVKLLIPKRKIIERVKGQPVEKIKLLFPGYVFVNAEMSDDLYYKISEVLKRGIFLKEGKRPAFVKEEEMKIILSLTKNSDLisKGIMEGERVKIIEGPLKGYEgiKKIDKRKKRAKVIFSIAGELKSVDLAIEVME--    
227 UniRef50_B8INV2        NusG antitermination factor...    95     6e-19  1  16.5%   2:159   6:175     -KTWFVVQTGPARERRVVELLAREGADTWLPLFRVTTVRRGRKVDDFEKVFASYVFAGLDEETMRRrvLFDCDHVLDVLGVD-RPLPFPADALQVLADRLAGHNRDEtkIQVGEMRRIINGPFMSFFAEVEEVLSNGIIKAGVRIFGRITPVEFTPDQL---    
228 UniRef50_Q7UWN7        Probable NusG-like protein-...    95     1e-18  1  18.9%   4:162  26:183     ---WWLLYTKSRQEKAVIRKLRDAGVPHYAPMVkrFRSPAGRMRESFVPLFSTYVFLRGD--DQARYEAICTGSVLKASEIVQVPDLIEDLQQIRSLIVMGVPLTIESQLQPGEHVRVKNGTFAGYEGTVIRRENETRLLVFVRFMEQGVSVKLEDCQLEKI    
229 UniRef50_B0MWZ3        Putative uncharacterized pr...    94     1e-18  1  18.2%   4:162  10:178     ---WYALKVFYNRVFELEKQLSQEGVRSYIPLLHEDTVAGDKKIRKRKPAVSSLMFIRQslLELQDRMKASCPFMAYFDRETKKPAVIPDREMELFMQITSADTSDLEYfrSGDKVRVTGGPFKGAEGYIKRIRGNRRLVVALEGIIAVATTYIPGRFLEKM    
230 UniRef50_A6E8J5        Transcription antiterminato...    94     1e-18  1  21.3%   1:141  11:153     VQKWFAVYTRPRWEKKVEQQLKMQGITCYCPLRKVQSQWADRIKVVELPLFSSYVFVCIHPREEL--NVRLNIGVVNFVYYMGHLAEIRHSVIEEIKSNLEkeIVSMRDLEVGDRVRIKAGLMGEQEGKVLQVRGKNVLLV---------------------    
231 UniRef50_A5IXI2        Transcription antiterminati...    94     2e-18  1  17.2%   4:160   6:195     ---WYMISTVSGKEDKVVESLKNRIveCflTTKEAEKKALGeyKVKMSNMYGGYIFINMDMTDKAWFVVRNTQYVTGLIGSAgkPTPVTKKEIDLAFEKEKQLIEDfdKFTVGEIVEIIDGPFKGTIGKVLEANEshKVTVEVEHFGKKVPTDFDYSVVE--    
232 UniRef50_B3PLY8        Transcription antiterminati...    94     2e-18  1  12.0%   3:160  11:194     --KWYMISTVSGKEDNVVESLKNKIseCfmpkELEKKSKGEEYKVKYLNIYKGYIFINMIMTDEAWYLVRNTQYVTGLIGSSgkPTPISTRNFEKMVQKEIALAEkeTVFKEGVIVKITSGIFKGEMGEIVKNNdtQKAFVNIEQYGRKVPTEIDHADLE--    
233 UniRef50_A6X1C2        NusG antitermination factor...    93     4e-18  1  15.7%   4:162  51:217     ---WLVLQVMSGRELSVREALGKENIEVLVPMKMGPKIRRQGREikKQPVMNGYVLARCMISNECLAGLLSFENVVSILGGYETPFLVSAEKVFVFRAKAEDGQYDYEHFHRkkWARVADGPFAGCRAELVstKGNGLVVIEVSIMGRPVAMTVPIAILEPL    
234 UniRef50_D0I9V3        Putative uncharacterized pr...    92     5e-18  1  19.6%   2:159   4:162     -YRWYAVYTHFNEEKVLRDELLAKGYEVYLPERKLWETLGNRRRVTYEPLFKCHLFVRTTPEGLK--NVKQAQGFSHLVRYGKYVATISESHIIKIKTIleDATSVSNSNVEGLAVAVVNGPLKGMIGVLPAGEGERPIAMEIGQLGYSVNVTVPMDTI---    
235 UniRef50_UPI00016C34F5 transcription antiterminati...    92     5e-18  1  15.7%   3:161  12:172     --RWAALRTAARWEKAVTEQLAAAGVPVFLPLLTRVSRTKSKTQTAQLPVFPGYVFCGEREYRDSTRVPPSCRKLIAQLLRAPDPDQLKDELRSVADLLANRQLLQERVyvIGDTVRIVGGPLAGSLGTILRLKptRRVLIEVSFLGARMEATVEERLLEK-    
236 UniRef50_B9YBN1        Putative uncharacterized pr...    92     6e-18  1  14.4%   2:161   1:169     -MSWYFIETERFQEEQVKETLLNSQFDAFAPKKEMYFKKGDLTTLTLRFLFPGTVLIHDPASPPQFAKkrNQPGSEGIHREADAYFSLASDEKETLEQLLNEKkqFSTGIIRNKELHVLKGPLQGHEKEIQKIKRHQRLATliKLCGQTIPLILGLEVIEK-    
237 UniRef50_B6GA74        Putative uncharacterized pr...    92     6e-18  1  17.0%   3:161   4:171     --QWYVIQVMKGREDSMASLIGRVvqEVFSPKYETEIKVRGRWVPVQKTLLPGYLIAVTNDPEGLEAVLRDLPEFARLLAQGNEFVPLAPAEVEVIGSFTSPGKRVVPmvKDGDRVVVTGGPLVGHEAMVKEIWRRKSIAIlvNMCGRVVTTRVGLGVLSK-    
238 UniRef50_Q73PT3        Transcription antiterminati...    92     7e-18  1  13.8%   2:161   1:171     -MDYYVVQVSTGKEKNfkNKFDELSYSIVFPQRILKIRKAGKVTEKQLPVFAGYLFIGTdiSKDLYQHLRKCKGFYRFLPNNQEPKFLEGRDFEILNQFISFgkISQVVFDENDRIKVIEGPLSGLEGYIVRVNKRkrATVCLDMCQTAFSIDLGFEILNK-    
239 UniRef50_C3RM78        NusG antitermination factor...    91     1e-17  1  15.2%   1:158   1:164     MknWYVLFALVAKENKLCSVLRRKGLDAFIPKIEYY--RRDIKGNTLKMLFPGYIFVRSEMKQSDFDNleQRDGLIKQLKDDGV-TALRDEEIEMFNKLLNSEGILEMsfIEDNKAKVIYGPLIHYQDHIVKIDKHNRIAIliEFLNRHILAGLEIKS----    
240 UniRef50_D0D588        Putative NusG antiterminati...    91     1e-17  1  19.3%   4:153  45:207     ---WYALLCRPQQERHAESWLAARGVYAFHPVTSRRTRVRGKLREYERRYLPGYVFARFDGIPIPHRVLTS-PFLTGAlrSDGQWGVLGPKRLAALHEMRARDLRQEDERQEQkrAMFRAGPFEGMSCEVVEIDAAGGVKVRFDLFGRENSVT---------    
241 UniRef50_B0UIZ3        NusG antitermination factor...    91     1e-17  1  16.0%   4:159  52:215     ---WLVARTRPRWAPRVVRDLAALGLCAFEAREEVERvpDGARRRVAVPLLHRLVFLGL-RDDADLARAEAHPGVLRVLFREGRAVTIPAPILQAFADAleDEAVEAVLLALGDAVRVTRGPLAALRGTIEAVDprRRYRVALGLFGRATRVDLAAEEV---    
242 UniRef50_Q5LG31        Putative transcriptional re...    90     2e-17  1  15.7%   3:161  16:173     --HWYLAFTASRAEQRVKQELDQRKVRNYLPLRKITYQWQGRSREALCPQIARCVLIWTSLSD-----IRQLSGISGLIIPQNIwyRVPEWQVEsfSQMDTAVEWIPDCLESATMVRVTGGPLTGLVGELDTSDTGFRIRIRFHSMG-CFRVAVPEEWIEK-    
243 UniRef50_A6TKC4        NusG antitermination factor...    90     3e-17  1  14.3%   7:160   1:159     ------MHVKSNEEMKAKKLVEKEiiKVIVPQRIIPEKRQGETRHVKKILFTGYLFLNVELDVDTYYKLKRIPSIHRFLGL-EKPEAIPLEEMQRVLRLCNQGelSKVIVKEGNKVQVVSGPLLGMEGHIIKVDKRkrAKVCLSVLGDAKTVDLGIEIIK--    
244 UniRef50_A6L134        Putative transcriptional re...    88     7e-17  1  15.7%   2:160   7:174     -MQWFAMRATYRRGMQIKGLLDQKGINSFIPMRYEIHLKNGHRRRELVPVIRDIVFVHTTQSELQRIKYGIPYFQYMMDIRNGEKIIVPDEQMRRFIAVAGTYDEQIIFFSPDekVRITGGQFEGYEGVFVKVKgdRRVVISLQGILALAMATLSPDLIE--    
245 UniRef50_UPI000174528A NusG antitermination factor...    88     7e-17  1  25.4%  26:159   7:142     -------------------------VETFCPRIRFQRSTPRGKVWFVEALFPSYFFARFVYSEAH-RAVKHTHNVIRIVGFGGDPAPIPDLTIENLREEMQGAELREVKyeVGDTVEVAEGPMRGLKGVVESlsGEQRVKLLLEFLGRQSLVEVQASKL---    
246 UniRef50_B0SHW0        Transcription antiterminato...    88     7e-17  1  17.5%   4:157  13:170     ---WYIVYTKPRAEKKLSELLRKYHIENYLPIRKERKKWTDRFKWIHVPVLPSYIFVRIVFWRDK-NKVLQLPGSVQFVFHKGQPAIVEQNDLDVLEkaESLKMNPELLLQKGKLVRIIDGSFVGKTMEIIKVKNKTLVVCRIPGVETIFSYEINMD-----    
247 UniRef50_A7UZ21        Putative uncharacterized pr...    88     7e-17  1  19.1%   4:160  10:175     ---WYAMRATYRREPDAMHLLKKENLGCFIPMQYKICIKKGKKVRALVPVVHNLLFVHARPSDVQRVKSQVTYLQYITDTRSGQKIIVPDGQMQRFIAVSGTYDDHLLYFQPDekVRITGGEFEGQEGVFLKVKgdRRVVIEIQGVIAVAMATIHPDLIE--    
248 UniRef50_Q1VSS9        Transcription activator or ...    88     9e-17  1  18.7%   2:151   7:156     -KKWFVLYTKPRGEKKLSEQLNRSGIEAYCPTRTEVRVWSDRKKKVEMPVLPSMLLVKI--ENKQRAKALESPLAIRYLFWNGKPSVVTQVEVDTLRSILGDSKFEShqLRPGQKLDMTELGFENIEGTVQYVNKKE-CWVVLQGIGYVVK-----------    
249 UniRef50_A6L7Z6        Putative transcriptional re...    88     1e-16  1  15.0%   3:162  10:179     --HWFALKVFYNKVFEIEESLKKDDIDCYFPCEDAVVMRNGVRKIIRKPIISSILFFHSTTLRAMEIQRQFTDKVILYTRDKevPLIIPDREMNIFMLVTSSGEKGMEyfCRGERVRVIDGKFKGAEGYICRIKKNSRLVVAIQGVCAVATSYIPQSFIQKI    
250 UniRef50_A7V7E7        Putative uncharacterized pr...    88     1e-16  1  23.5%   3:138  67:218     --HWYALRTTYGREKKAYDYMTAKGITAFYPTTDTVKLIKGKRKIVTESRLPNIFFAYGTEEQLKTFVYDNvrFYYRHVHVGRrpMIVPDYQMESLKIICAADaiEVPKFEKGQLVRVIDGAFKGVIGRVARWQGQQR------------------------    
251 UniRef50_Q8VSS9        UpdY n=24 Tax=Bacteroides R...    87     1e-16  1  16.4%   2:160   7:175     -KSWYALRITYSRELAFKEYLDSRGVRNFLPMRYEYVFRGERKIRKLVPVVHNLVFVYATRSEVDEMKStsLPIRYIMDRETRQPITIPEVQMRSFIAVAGNYDEQVVYLDPsdRVRVTGGIFEGVEGEFVRIKGDRRVVVSIQGVMAVATAFIHPSLIE--    
252 UniRef50_B0VET3        Putative uncharacterized pr...    87     1e-16  1  15.1%   2:160  23:179     -RKWVVVHTKPRCEKKLADYAKQHQITYYLPQYTSKRVYQRRKVDVNKVLFPSYVFVGIDFKGKQELLISG--YTVNFLKVNAQKELIDELQAIYYGRQKNVQMEPGLWLEKGLEVEIVNGPLKGIRGVVEDQSKLTEVRLQVNILKQAVLVKVRTQDIK--    
253 UniRef50_B1ZWG3        NusG antitermination factor...    87     2e-16  1  12.7%   4:160  23:177     ---WLVCHTKPRCEKKFAALMAAERFEHYLPLVDSVRKYRQQTKRFTKPLFPGYVFACVPNEKRAR--IFQQDLLARAIDVDDERRFLRQLDDVRAIVASGYELTVLPLLTRGRRVKIVGGPLHGLEGFVDDPSNPRGVVLSVDVLQQGLLVKLPAENLQ--    
254 UniRef50_Q6MDM6        Transcription antiterminati...    87     2e-16  1  18.6%  50:162   1:117     -------------------------------------------------MWPGYLLIKMNLSDESWQYVKNTNGVIDFLG-GDKPTPLTDFEVGEILKDLEDKKrqKHKFEVGDRVKITDGVFVNFIGTVTEvhDKGRLSVLVSIFGRDTRvdLEFVQVEEI    
255 UniRef50_UPI00016C58F1 transcription antiterminati...    85     6e-16  1  15.6%   2:161  24:222     -KKWYAIKVQSGREDTIKAAILRKIaqIMVPVEKVIEKKaeRKVERKVKKFQGYIFAELEFNDRLLYLIRETSGVGDFLkdTPVPEPMSDAEVKQMlgPEKGPTKVKVDFEKGDRVRIKEGSFKDSEGDVKDVILPkkVIVTVTFWGRPLDVELEYWQVTK-    
256 UniRef50_Q8AAK2        Putative transcriptional re...    85     6e-16  1  17.4%   2:162  14:183     -KAWYAVQTFYCKEEHLGKYLEKKGVNYFIPMRYIeeTLDGKKHRKLTPAVHNLLFIEKEFTEkeRVKDCTIPFLLVRDRSTRRCYEIPDCEMLEFRAVCDPndTVTAEARPGQAVRVIRGPFAGLEGKLTQYKKSYYVVVTLATIG--VMLHIPKWYCEKI    
257 UniRef50_A6DPM2        Transcription antiterminati...    85     7e-16  1  25.5%    3:96   6:114     --QWYTLQALSGKENKARQDLERRilEVLLPTEKVTTVRQGKKITQNRKFYPGYLFVNVdmKEDVWHFVKNTYGIINFLG-GDKPVPLSDDEIQIL------------------------------------------------------------------    
258 UniRef50_B1C1D4        Putative uncharacterized pr...    85     8e-16  1  14.9%   2:149   1:165     -MNWYVLYTLSHRTQRILGNlkKKELEAFIPSYEVCHRYT--KEITIKPMFNNYIFIKTMLNQEEFNTleDNNGLIRQLKNADTSA-LTKKEIEFFNLVLDSKHVVrhGYQENGITRVISGPLVAYENHIVKVDKhrRIKLGIDILGKK-------------    
259 UniRef50_B0NP97        Putative uncharacterized pr...    85     9e-16  1  18.0%   4:153  16:175     ---WYAVRTFNCQELKISDFLKERKKVHFVPMTYVEKEKEGKTRKMLVPVVHNLVFLQKNESRKATLAmcNVPFSVLCDKETKHPCEIPDKQMTEFRILCDPdtHEEAEAKPGKNVRIIHGPFAGITGKLHRARGGYYLIKTLAGVGVMMRIS---------    
260 UniRef50_Q2NTN8        Putative uncharacterized pr...    85     1e-15  1  25.7%   1:144   8:147     IMSWYLLRFKATLFNMVFNHLAASGVYYFCPMIETQYRRPDSvrKRLSPVFPGYLFVNLDFDHCHPQKLSAHRHIYGLINFGQGPSPIDDAVIDLLMAKPHIVRKIIDAPRAWKE-------MSELEKIMYICDDEQRIAAFLN------------------    
261 UniRef50_D1CTG7        Transcription antiterminato...    85     1e-15  1  22.9%  40:157   4:123     ---------------------------------------RAQHRTVCSAYFDCYLFVSLDIRQQRWPPINSTVGVRRLVMSEHAPLPVPHGVVESLLAATDDEghPKELLEPGQKIRVTNGPFTDQLGTLDYVGRSGAVRILIDIMNRAVPIYIDRD-----    
262 UniRef50_Q5LF44        Putative transcriptional re...    85     1e-15  1  20.0%   3:162  27:196     --NWYALRITYGRELALQEYLNSEGIENFIPMHYEYTIKNERRVRKLVPAVHNLVFVRSSrdAIKESKGTTLPIRYIMDREYHRPIIVPDSQMRNFMAVSANYDESLLYFEPSerVRITGGLFEGVEGEFVRVRNDRRVVVTIEGVMAVATTFVHPSLVEPV    
263 UniRef50_C6QJC2        Putative uncharacterized pr...    84     2e-15  1  19.0%   2:159   1:181     -MTWYAIRTNPQREFLLAGrlEKKGYdvFCPTETKFRkkKGRRVsvLYPMFCGYIFVGGRF---SWLELMAENYITAAVGFPdrPAPISDYEMAKLREMSGGLIPHRRsfRVGEMAAIAAGPFAHQVAQIAGLHGTK-ARVFLNLFNGTREVEVDLDML---    
264 UniRef50_B6TZG2        Transcription termination f...    83     4e-15  1  17.1%   3:160 104:325     --QWWLVRvaPGTdkAISRRYSEVPFKIYNPSIQVKRrkSGAISVKSKPLHAGLVFLHCTLNKELHDFIRDTEGCYGFIGAtkKPKPIPVDEVESIIREEKEEQERVDrfSPGATVHVLSGPFADFTGSILEVNRkkKATVQLSLFGKESFVDLDFDQIE--    
265 UniRef50_A6LD20        Putative transcriptional re...    82     6e-15  1  16.5%   3:160   8:176     --DWFVLrtRPNAKRPAYRLLEEKGIEIFTPMRWRLVERKGKRIREEVPLLHDLLFAHTTRTCMDPIVEEISTLQYRYLRGgrKPMTVGHAEMNRFICAVHSDDSPRYFLVEerMIRIEGGPLDGYEGRLLSIRGTRVKRLIVEIPGLLvaVEVDPKYIR--    
266 UniRef50_Q9EUG2        Actx protein n=1 Tax=Escher...    82     7e-15  1  25.5%   2:146   1:134     -MKWYVLQFTTTRFAAVFKHLERLNFSYYCPMATEKYRRPDkyRERLTPLFPGYLFIQADFDEVHTTTITGLPHTQRFIAFGGEPLAVPDDEV--------------CNVQKGERNLLNFDEYPRLVEIMMMSEPRMRSMAMLNYI----------------    
267 UniRef50_C6ICX6        UpaY n=18 Tax=Bacteroides R...    81     1e-14  1  18.2%   2:160   6:168     -EYWFAARTRKDQELTTRDALEKIGVEYFLPTQFVIRQLKYRRRRVEVPVIRNLIFVHATKEFA--CAIANEYGVRLfdFDTKSMLIVPDKQMKDFMFVMNLDPAAvdCFAVGTKVQVIKGDFCGVEGELASLSNRTYVTIRIRGV-LSASVKVPKSYLR--    
268 UniRef50_Q2GD85        Putative transcription term...    81     1e-14  1  17.2%   4:160  12:173     ---WCVLRVRSGSESKVCDLIKSrvVDLFSPALVKFDASASKR------FLPGYVFVKVVPGSAFLSEISVMRSLYgfLNQAGSPKFLSDKDIDEMRNFMLSPEVTPekISVGSRVAILCEYFEACVGEVDEIDErsKAKVKIVFCGQDVVVSFNLDQLK--    
269 UniRef50_B7UF78        Similar to transcriptional ...    81     1e-14  1  32.2%   1:146   1:141     MFNWYLACHQPGKEtkAQLELSRLHIDSFCPLIRLSRPRPDRprLIIEPLFSGYIFIQFDPEITHTTKLTALSSVSHFVKFGCDIRPIPKTVIESLMKL-------PLCPTEQD---VIAGRFKeiVAITRVSNKHERTVMFLALM----------------    
270 UniRef50_Q10BA7        Os03g0825500 protein n=3 Ta...    81     1e-14  1  20.0%   3:162 105:328     --QWWLVRvaPGTdkAISRRYPELSFKIYNPSIQVKKrkNGSISTKSKPLHPGLVFLYCTLNKEVHDFIRDTEGCYGFIGAtkKPKPIPVEEVESIIREEKEEQERVDrfTPGASVHVLSGPFEGFTGSLLEVNRkkKATLQLTLFGKESFVDLDFDQIEAV    
271 UniRef50_C8WIA4        NusG antitermination factor...    81     1e-14  1  19.7%   5:161   9:172     ----YVLQVVPGRERAVAERVkeLVRDCFALSYCILKKNQGVWRLLTETMFPGYLFVASDDIEAFEKTIKRSTAFARLLGAERRAFALRPEevHDFGGPSHVVGFSRGTIDNGRTI-IDEGPLRGHVDRIKKIDRHKRIAYliGLLDQKQ-VRVGLEIVRK-    
272 UniRef50_B9QSZ2        Putative uncharacterized pr...    81     1e-14  1  20.6%   3:162  30:200     --DWIVVRSNPNCESRAAESLSAAGLIAWLPMLPVLRKNSRTRNekSRPLCTRYLFVALDRYkqSTSEVVVCDGVEKVLSFDerPHIVPKAQMRVIVEQceGNLSKVKHFDIGAVFGLLADEFDGVTGTVTGYDEAKGIvgLVPMFGREMAVKVAVDKVKAV    
273 UniRef50_B1AJM2        Transcription termination/a...    81     2e-14  1  15.2%   3:160  25:247     --QWYIVTVVSGNEQKVIENIKDkeVKIYEPSEAPRSMKNrcTKIKEGNKFNGYIFLKAEMTDQIWFLIRNTQMVTGLVGSSgkPIPVPEDKieNIEVIELHEDENFTNFEVDQEVKIIADTFFGEIAKIAKIDQNKKIavEFEFFGRINTLDLNFNDIQ--    
274 UniRef50_A9BF38        Transcription antiterminati...    81     2e-14  1  20.2%  49:162 231:352     ------------------------------------------------NLFPGYVFVEMMYIKETEELVSNLPYVSTILNIGGKPVKLNKNEVRFVLRVMGEekEVRTDFELGEHVKIINGPFEYFTGKIKDFDLEKqvQVVVTMFGRETTVTLSLGEIEKI    
275 UniRef50_B7QPX7        Putative uncharacterized pr...    81     2e-14  1  18.0%  21:159  65:214     --------------------LQKAGFEVFLPIKKEWSRVNreQKLKCRPAMEGWLFVGWAAGQARFHELMALDVVSGVMGAGGQPVRISDAKVrrLRRKASNVEAEPVRFSVGDLVRVDAGPFEGQTVSLLDVSG-GSARAVMTLLGKDVEVDLEQEFL---    
276 UniRef50_B5CYV1        Putative uncharacterized pr...    81     2e-14  1  18.4%   3:160   7:173     --KWFVMrtRSNAKIPAYQMLDDMGIENFTPKVTKIVTRNGKRERKELPFIHDLIFVHSSRTVIDPIVERVHTFQYRFLK-GREPMIVRDKDMASFKQAVEssPQDITPCMFKRKIRIIGGRLDGCEGYLLTVRGSKRKRLLVELPMLItaVEVEPEYIQ--    
277 UniRef50_D1N7B2        Putative uncharacterized pr...    80     2e-14  1  18.5%  17:162   2:152     ----------------VAQKLRNAGIACYLPVVPRAYMMHSTKVITEVPMFPGYLFLCLGRFEAADLKIREKKIVKIDLQFDEGREALLIDELHTLQRCEALAKTEPILINpgDKVLITSGSLAGLVTEVVRRDdhDAIIVNVTLLGQHIEYRLPAEKLKKL    
278 UniRef50_C3RM77        NusG antitermination factor...    80     2e-14  1  16.5%   1:158   1:167     MMNWYLIFANDNKINDLLLYFNNheMTAFVPKIEKLMKKDGKKVFAEVPMFPNYIFIESEFNSQEFYQikDMDSTMRIMQSDEQKVllANNEKELLESLFNDDhiRSIGVIVDSKLIVQDGPLVGKEEMIKKIDRHKRVAFIGDVFGKTMKVPLEVTS----    
279 UniRef50_Q6TFR9        ORF9 n=1 Tax=Erwinia amylov...    80     2e-14  1  21.9%   1:155   1:149     MKNWYVLAFTSNKFGAVERFLKLNKIEFLCPMHEHSYSRPDkiRKSLVPTFPGYLFVYLDFNETHPEKLARFQYIYGLITFSNAPMAVPEVTIQVIAYTCSVVKTASSVK------KIISHDFA---AILLTEEPKKRSVMLLNYLCENHSQSVK-------    
280 UniRef50_C9Y5P4        Transcriptional activator r...    80     2e-14  1  37.5%    1:96   8:105     MYKWYVLYCNSQDIQRISRRAEDIGVEVFCPRYIKVTPRTDCrrQEEKPLFPSYLFLRFDVNVVHTSTITSIPGAHGFVSFGAAPCTVPESVITAI------------------------------------------------------------------    
281 UniRef50_A7V9P1        Putative uncharacterized pr...    80     3e-14  1  13.7%   2:162  28:198     -KYWFAARTLSKQEFAVKKRIENLnvECYLPTRTVISQLKYRRKRSVVPVARGLIFIHAT--KQSACDIHNVYGVQVfdFSTHSMLVVPDKQMQDFMFVMDLNPEGvePLTVGKKVTVVKGEFSGIEGEIATEANKTYVVIRITGV-LVASIKVPKSYLKAI    
282 UniRef50_D0XNC5        NusG antitermination factor...    80     3e-14  1  22.2%   4:156  15:184     ---WFVVITHVNQEKLAKYQLERQGHAVYMPMvpRARMRNGVPPSV-RPMIPRYLFVQVDLDQPGWPAIYSTFGVSEVigEGRRPRAIPTRFIEEIRAReaGPAPVACRFKKGDKLR-WHGPTADYEVVFQQMVDGNRAEVVFTLMGVDSRQVISL------    
283 UniRef50_UPI0001C34E8E NusG antitermination factor...    80     3e-14  1  19.4%   2:140   1:147     -MSWYVLYCRPGQETEIIESLKQRlsEAFlqCERLWRAGGGNWKLIRKEMFPGYVFLESEDSEYLSEKLEAYRGIVRVMEEPGYLIPVYREEEERLRRLCGPEHILryGYRENGVNHVVEGPLKGMERQIVKADWHRRFA----------------------    
284 UniRef50_Q1QI72        Transcription antiterminati...    79     4e-14  1  13.5%   2:142   4:135     -RYWGACRTFTGREHLVRAKIEEMDRGAFLPTFVRSWIAGGKLSVAERPAVPGYVFFRASQDD--WSPVQDIDGVIGVLANGGRAMRISNDDMASLVIGHAAGAHNRFE-------DCISSPSRGSRRKSRKPRPSKRARLR--------------------    
285 UniRef50_C6I4Z2        UpcY n=5 Tax=Bacteroides Re...    79     4e-14  1  15.9%  24:161   2:142     -----------------------QEVDTFLPVQNRVIEREGKRIERERLLLPRMVFVHISRQEM--AAVRSTLNVYDFlrSTGAPTCIPDAQMADFRYMLDYSQDQveSIPKGTRVVVAKGDLQGLRGELVRYNNKYHILVRIDMFGSAM-VTIPASYVRK-    
286 UniRef50_B9Y881        Putative uncharacterized pr...    79     4e-14  1  11.6%   2:156   1:164     -MRWYFVEVEKHHEEDVLELMKSSPFEAFLPKKQRYFKKQVLVTWVERLLFPGTIMITSDFPQAEFTklSQHSDISQWIHLEEkyFSLQEDERLFLNSLMNEQHVIptGFLNEKQLIVESGPLQGLESRIKKIDRHQraQVRFQICGQMMLLNLGL------    
287 UniRef50_A6LE17        Putative transcriptional re...    78     6e-14  1  15.8%   1:146   2:156     MKKWYALKVFYNRFSEIKATLSRDGIESYIPMKTRSyqPDGEVVIRRVPLVAMLMFLRCDDDYisLNSILDEKAMVYHRPGTQIPASIPDEEMDMFIMLTSSMEDGFEQikNAEKYRVTGGEYAGVVGYYRRIKKNKRLVIPFEGL----------------    
288 UniRef50_Q4A648        Transcription antiterminati...    78     8e-14  1  20.0%   3:162   7:199     --RWYLISTITGKEAVIVEALKNRifKVfvPSITKTELNKKQkkVKWKNMFPGYIFVKADMQDLVWYIIRNTLQVtgSGGGGEKPTPVSQNQIRKSLEKEEEAKKLFenLKVGDLVLITDGNWVGNEAVIEKIieDNMAEISFEDFNKKVEFKINLDWLTRI    
289 UniRef50_Q7BQV7        Putative NusG-type transcri...    78     8e-14  1  28.8%   1:146   1:156     MERWYLACHKAGKDnkAQMTLERMNIMAFSPVMRAYRPRSDRprPVMEQMFPGYLFIFFDTEIHHSSKIELCPGISHLVRFAGEITPIRDAVVDDVM-QLPVCVQAFSRKNPGKRRwlNHQQRQQIQALVDTKDGDVRSALFFAFV----------------    
290 UniRef50_B9HCH7        Predicted protein n=1 Tax=P...    78     9e-14  1  15.9%   3:159 110:337     --QWWIVRviRGDerLLARNFPQMDFKVYAPSVKERRkkNGTYSVKPKPIFPGCVFLWCVLNKEIHDFVRECDGVGGFVGAknKPRPVSDDDMEafQQAKEEQEKADIGFEEEqtVRVVSGTFADFVGSLKKLNRkgKATVVVTLFGKESLVELDLSEI---    
291 UniRef50_B9NP65        Putative uncharacterized pr...    78     1e-13  1  15.7%  21:160  63:213     --------------------LRRAGFEVFLPIKKVLRRKNreKALISQPLLVDWLFVGWPVGESRWHDLMELDVISGVMGTGGHPIEFPAARVMSLMRQWGGGHLSSEcfAVGDTARVIAGPLDGVHVRVVDVSGP-TVKAALGMLGSEVVTEIRGDLLE--    
292 UniRef50_D1VYC4        Transcription termination/a...    78     1e-13  1  14.7%   4:153  33:194     ---WYALRLFTLKTQQVIDYLEEHHLDYFIPMEYvvEDRKHRVQQKLRPVVRNLIFIKRTMSELSIRKILTEasVIRKSREDSQYYEIPSRQMFEFQAMCNPEIVMRQYLSEAQavYVKYGPLKGLSGRLVRSNKKYFLLKEIPGLGVMLKVS---------    
293 UniRef50_C5B0S5        Putative uncharacterized pr...    78     1e-13  1  15.7%   2:160   5:185     -RGWLIVRAQLGRFSQVVEGLKSAGCPVFEARREIRVQTDGKPKVTNAPMMGRTLFVGVEEPEYA-CLLAGLDYVHGILCRGerPAMIPPKMMTEFADhkGVQDFVETLFSVGDEVRISNGAFATFMAKIEGVdkRGRYTVAVDVFGRPVPFEIAEESLE--    
294 UniRef50_A4E6I1        Putative uncharacterized pr...    77     1e-13  1  14.3%  27:159  16:152     --------------------------ELFYPQYQTEIKVHGEWVSTTKPLFPGYLICDTADPRTVQQYLLRMDDFARVLSQDGQFVPLAKEeiGSFTNRGDRVVPMSEALKDGDQVVVTAGPLLGHEGLIKTINRRKSTalELDLCGRRVTTRVGLAVL---    
295 UniRef50_D1XYZ0        Transcription termination/a...    77     2e-13  1  18.5%   3:153  18:180     --SWYAVRLFTLRLKEVKAYFEALDYECFVPMQYviEKPEGGVKHELRPVTHNFIFVKQTMSEASFKkaNFKINVIRKVDDVTQFALIPSKQMYDFRMMCNPEieREAQMKAGDPVLVKYGAMKGMTGRLVRSNKKYYLLKEVPGMGVMLKVS---------    
296 UniRef50_C5VMP2        Transcription termination f...    77     2e-13  1  16.7%   4:153  18:179     ---WYAVRLFTLKLEEVRTYFTSHGLECFVPEQYviEGHDGKPHSILRPVVRNLIFVKKPGEDISFQKinYKISVVKKAKDSQEYALIPHDQMYEFRLMCNPEITMRKFlkAGDEVLVKFGPLKGMIGRLVRSSKKYYLLKEIPGIGVMLKVS---------    
297 UniRef50_C3RR25        NusG antitermination factor...    77     2e-13  1  12.3%   2:156   1:163     -MYWYVARCKTGRTKKLVSTLNKqnMNAFIPKSERCFGRGETAEFIVKEIYPDYVFIKSDLDQEAFDefKTINGLVDLLEYKDTYPLTSEEQSLLEKLLDNTDTIKHTKGVIVDRRFvtDGPLVGLEDMIKKVDKYRRFATltEIFTGKLLVAIDY------    
298 UniRef50_B0ZDY9        ActX n=5 Tax=Enterobacteria...    77     2e-13  1  21.9%   2:161   5:155     -KQFYLLQCSPHFHQSVLLQLSRSGIAYYNPVIRTFYKRRDcyRGQIMPMFPGYVFVLLDFEVVHPSCFTRMKNVYGLVSFGEYPAEVPLSVINEVKEQEKIFSMNLSLMNNSCLAKI-----------LLLADASKRGQVFADYVCNRKYDRLKNDSYKR-    
299 UniRef50_A4EPJ2        Transcription antiterminati...    76     4e-13  1  14.5%   4:162  33:202     ---WFVLKVQPMKEFEVEMWLGQqvLEAWLPTNKAWrrGHRRKVQYRQKIAPGYVFACVERRIAWDLLQRRSNgvLGVVGYNGRPLPVPEEQMRAMkqKIYAEAQSVKLVRPGDKARIldGPMCDWVVDVTEVNG-GIAKILVPLLG-EREAQISMEQLERI    
300 UniRef50_UPI0001972DAA NusG antitermination factor...    76     4e-13  1  15.1%   4:149   2:160     ---WYVIQTTTGKEEELAGIVRRNVShcFSMKRELLKRLGGRWTAVTETMFPSYVFLETEQPERLFYELKRLPEYTRLLGDNEGCFIPIEKEEENFLNILRRNEKETcdLDEDGGIRKADGPLQFFLDKIVKLNLRKraVVELKVAGKE-------------    
301 UniRef50_C3RR26        Predicted protein n=2 Tax=B...    76     4e-13  1  19.4%   2:156   1:161     -MNWYVLYVFSNKTNKILSNlqRKELTAFIPKTEVF--HRQAKKKTTKDMFDNYIFVKSDLKQNDFNDLlkNDGLIKQLENAEVSA-LREKEIEFFNNILDKDNVARVsyQEEGKTIITEGPLLHYQDHIVRvkHHCTAQLDLPFFDRKIILGVEL------    
302 UniRef50_B2CBC8        Transcription antiterminato...    75     6e-13  1  34.4%    1:96    1:98     MYEWYVLYCNNQDVERITRRVEGLDVEVFCPRYIKVTPRKDCrrQEEKVLFPNYLFLCFDVNITHTSTITSIPGAHGFVSFGSTPCTVPKSVITAI------------------------------------------------------------------    
303 UniRef50_B7C7N9        Putative uncharacterized pr...    75     8e-13  1  13.6%   2:155   4:165     -EHWYVLLTIRSKEEEVCKYleNDGIYAFSPKMEFYHRVS--KQIQQRSLFGGYVFVVSKLsdAIFKKFPLQSVFIHELKYEEEVSALTDEEIRILNMLLDDEKVLRMSylVNNKIHVTQGPLKNMDDYIVKYDKHNRLATllSFLNqkVGVTIP-------    
304 UniRef50_Q98R28        TRANSCRIPTION ANTITERMINATI...    75     9e-13  1  14.6%   3:160   5:190     --NWYMISTIPNKEKEVIEAIKNKVveAysAKELEKKQAGDSYKTTKKNMYNGYIFIEMVITNETWFLVRNTENVSGLVGsgAWPTPISKLKFKKMIEEETKKEEEFqkFREGLFVKIVDGPFKNDE-IVYKIKkkKYSILEIESLGKSVDTQIDHKHLK--    
305 UniRef50_A6LGY4        Putative transcriptional re...    74     1e-12  1  17.1%   3:160  15:183     --RWFVMRAYKN-EKMAEDRLKDkgLEYFIPKHYAVKTYHGVKSTRLVPVIPSLVFVHASHSQITEFKKRylQFAMWKKSTGMEYITVPDDQMDSFIQIASLYEKDTAYYKPDerVCIHGGKLDGVKGVFMRVKGkrRVVVMLeiMG--ISAEVHPDLIE--    
306 UniRef50_A8T9L1        Putative uncharacterized pr...    74     2e-12  1  27.8%    1:97   1:102     MKNWYLVYCNVKNSRrlIRFLNSFGVEVFNPIMTYYKARkgKFRKQTKSLFSNYMFIQFDCTKFSFSKFDNIEGISYFLRSSGQIATIPEPLIENLR-----------------------------------------------------------------    
307 UniRef50_A4E6Y7        Putative uncharacterized pr...    74     2e-12  1  14.0%   3:138  28:171     --RWYLVHTPNGKERETCEKVRCIiqDAFVMQKEFWFKRDGAWSLQTKPMYKEYFFVATHDAAALDRALAQLSFGCRIAGSREryMPMPDDAQDWYRSVLDEDGVVRNSviEDGVLHIEQGPLVGQEARVHKIDRRKR------------------------    
308 UniRef50_B1C0R1        Putative uncharacterized pr...    73     2e-12  1  15.5%   1:155   4:166     VMYWYVIHAKvrGSKIVKFFNSQKGVDAFIPKIEKWHNVKSVKDYVIKDLYPDYVFVKSDMDNEAFNkfESIEGFGELLEYEGVYALKDTEQDLMEKLFNGGHIIKRSIGNIVDKKLIVdgPLLGLDDLVVKINRHHRVATltEFFDKKIMVPLE-------    
309 UniRef50_B6W2H1        Putative uncharacterized pr...    72     7e-12  1  14.6%   4:160  12:187     ---WYVMRVYKN-ENTAEDRleTYGLEYFIPKQKVLRTVKGKKVFFMVPVIHSLVFVHASHQKIVDFKHNYYyfVTWKSGGELVYLTVPDEDMTNFIKVCKQADEEVHFYKISerVRVHGGPFDQVEGYFIKvkKRGRQLVVidLL--AVSAEVKPEYIQ--    
310 UniRef50_D1W4R5        Transcription termination/a...    71     1e-11  1   9.4%   4:152  30:190     ---WFAVRLFMAKPQLVMDYLTEQQLHYFIPMEYvvEDKDHHIRQQLRPVVRNLVFIKKSKPEKarQLLMDAPfvIRKSKDDSKYYEIPAKQMFEFQAMCNPEIAMRKFLSEEQavYVKYGPLKGLSGRLVRSNKKYFLLKEIPCMGVMLKV----------    
311 UniRef50_A6UAQ8        Putative uncharacterized pr...    71     1e-11  1  12.9%   3:149   5:167     --RWYAIRTAPGyeSIIERNCRKDGFDIFMPSFYKELKHHRTNEIIEkpFLVGYAFVNLPR--LNFEELRRVDGAVCFLRGAngPLEFPSATIEALYFAEHERRQAFLYEQHCRKENERHEQIQHLRGQLRKILPKGR-KARVSMVDQA-------------    
312 UniRef50_Q984H9        Mlr7998 protein n=1 Tax=Mes...    71     2e-11  1  13.5%  14:161  20:195     -------------EIVAERSIRDAGFECYYPRMRKEIIHHRTNVRIVrpLFTGYIFVALPSANGEY--LKDCDGLGRLLSYDgkPWQVPTGAVESYMRAEAdrETIAMTFPEGQAIRVkkHMLAGFHGEVVSVTGRGTVKSMIELFGRLVAAEFDADDIEP-    
313 UniRef50_C3M8G1        Transcriptional activator a...    71     2e-11  1  30.1%   2:137   3:141     -KKWYLTCHKSGCSnkAQQALIQIEVHSLSPSIQTWRQRLDRkrAVIEPLFKGYLFTCFDPEKIPTRKIEHCAGISHLVRFANTIVPIREAVMQEIMRF-PLCMNDETRTNHKITTSLKESQKEQIKNIVQKKRRTR-------------------------    
314 UniRef50_C4UKL3        Transcription antiterminati...    70     2e-11  1  20.1%   3:146  10:161     --SWYLAQYITGGKNREKlwLCEQHITPWTPLTVRTIRRTDKINCIRkpLFPGYFFLKANLATQTVDNIRRHSAFCGFVMNGPQIAPLRPLIVEGLMKCHPDPTLSPEALNELESawLTTTQYQYLLSIEQDSRPVSRVTLLMKLV----------------    
315 UniRef50_C6IMS6        Putative uncharacterized pr...    70     2e-11  1  12.2%   3:150  44:199     --NWCYLFIHHTKVNAVNEKLKER-YCTFIHKSVVYKRKNKRIAKDEKPTISGLVFVQGESDDIQSFLCENFFGLYLvdCSTGKIAVIHNNVMQSFMQVSQVEPARIRFMPhnTLVRITSGPLTGLEGYRIRISRDKCLVTSIGGMTVAI------------    
316 UniRef50_A9NQH7        Putative uncharacterized pr...    70     4e-11  1  17.2%   3:136  80:240     --QWWMLLVPRNSERLVAEDLSKaeFQAYLPEIPSRRkkNGSYSESKKRMFPGYLFIRCPLNKEIHDFIRNTPRVRGFVGRKvkPKPVPIAEMEETFRKVKEEQEAYDIEIQEELLkiGQDLLEDLEGTDVRMKKD--------------------------    
317 UniRef50_B3JEC4        Putative uncharacterized pr...    70     4e-11  1  14.5%   4:162  32:202     ---WLPLQTVYNKELTVAAYLKEQGIEHYIPMTYELRdrEGECSHVLVPAIHNLIFIHCPY-DANwqFASEAPLPVYFlrNGNDYCTVSERDMQNFMHATNPDIQG-TRFIDSEKLrvRRGPLYGVTGKFLRYGGRHYIA--IEMPQSTALLKVSYTWCETI    
318 UniRef50_Q1GII5        Putative uncharacterized pr...    69     7e-11  1  18.1%   1:160   1:190     MTNTYAINTTRGKEFAVRDDLKAMGVNPWVPVRLGSRYVKEKRSAvdAAYVPKLMFAVIPA--IIWRDVLEHKHVIG------KPVALSRLDIEGIPGHVKKSteYQCQFKPGQALELLCPPWEGFSATFAKvdDYAKLRVELEIFGRVTPLDVDPDRVK--    
319 UniRef50_B9XD13        NusG antitermination factor...    68     7e-11  1  29.0%   4:103   8:107     ---WYCARTKPKHEHIAAANLLRhnVEVFNPRLRVEKATRRGVIRVSEPLFPCYIFVRCVIEEKL-NDIRYANGISTIVHFANRIPHISDSVVVELQEHFKEM-----------------------------------------------------------    
320 UniRef50_C3Q0J2        Putative uncharacterized pr...    68     7e-11  1  19.6%   3:160  12:180     --HWYAMRDLKRRHAkaYKMFENLKVQCFTPMVHRLVVVGGKRVDQEVPFMQDLLFVK-DTREHLDAIVESTPKlrYKLGVQHTPIIVPVADMERFIKAVEASDNPKFyeMRNRKIRIIGGQLDGYTGTLVTTRGSKTKRLLVELPtlAASIEVEAEYIQ--    
321 UniRef50_A3DNH9        LSU ribosomal protein L24A ...    68     9e-11  1  15.9%   5:161  10:153     ----YAIRTTMGREIDVALVIESRIMD-----LVKQNRDPGVKAVFVPPGVRGYVFLETSRLASIYRLISELKYVK-----SGQPIKVSLDEVGRLVKP----KPVIEMIKEGDIVEIVRGPFRGMKAQVISIDRNKN-MVVLSILEAavPITVPGDYVKP-    
322 UniRef50_Q79JX8        TraB n=17 Tax=root RepID=Q7...    68     1e-10  1  21.4%   2:146  54:206     -RNWYLAQYIpnREH-LFSWLSEQHVLPWTPLILKKVRRTDkyRRHIHAVFPGYFFLKADPERHSFTHLRRHSAFLDFVKMAGEIKTVREDIVQSLMKVYPDPALNPAAREELdtLWLTKARYQYLLRLDAQPLPESRIALLLHLV----------------    
323 UniRef50_A2BN62        Transcription antiterminato...    67     2e-10  1  18.5%   5:161  26:164     ----YAVRTVAGREIDVALIMEQRARDQNMPIY----------AIIVPPQIKGYVIVETPAAFYATNAIQGIRYAKGVV-----PGVLRYEDVERLLKPKAVIET----LKPGDIVEIISGPFRGMKGQVVRVSPSKN-EVVLNVLEVEYpiTVPGDSVRP-    
324 UniRef50_A9A583        NusG antitermination factor...    67     2e-10  1  16.0%   5:160  10:147     ----FAIRTTGGQEKVVMRLLEAKANANQINIQSVFWVND----------LKGYVVIEAINPSDAYMAVEGVRHIRGQLRGE-----LEFKDIEGYLVKKS----TVSTLAVDNVVEITGGPFKGMKATITRidKEEATVVLLDA-SYQLPVTVDANYLK--    
325 UniRef50_B8D5Q0        Putative transcription anti...    67     2e-10  1  17.1%   5:162  15:159     ----YAVKTTLGRELDTALIIGMRIDE-----MRARGEETSIGSIIIPPNVRGYVFIEVERLGELYKVISDIRYIK-----AGRPIKVSYEEFEKLLKPKPVIEE----LNVGDEVEITRGPFRGMRARIAGIDRNKN-MLTVNILEAaiPITIPGDYVKKI    
326 UniRef50_A1RX84        NusG antitermination factor...    67     2e-10  1  17.7%   3:160  10:149     --RFYALRVTSGQEYNVAQLLYRRA-------------ASGKYkiLVVPGLKGMVFVESDALYEAQRLAYGLKHVRGVVRGA-----VSLQEMEGLLKP----KPLVDQLNVGDFVEIIRGPFTGMRGRIVGIDKSRnvKVELAEAVFVLPVTINADDIK--    
327 UniRef50_B3CAR2        Putative uncharacterized pr...    67     3e-10  1  12.6%   4:122  28:150     ---WYVMRVYKN-ENTAEDRleTYGLEYFIPKQKVLRTVKGKKVFFMVPVIHSLVFVHASHQKIVDFKHNYYyfVTWKSGGELVYLTVPDEDMTNFIKVCKQADEEVHFYKISEINKEKDKP----------------------------------------    
328 UniRef50_P96036        Putative transcription anti...    67     3e-10  1  18.8%   1:160   6:148     MRNYYAIKVVGGQEINVALMLEERI---------KTNNIKGIYAIIVPPNLKGYVVLEAEGLHIVKPLIAGIRNARGLAQG-----LLPRDEILKIVSRKTVGPT----VKPGDVVEVISGPFRGTQAQVIRV-EEAKGEVVLNILESAFpvTVPLDQIK--    
329 UniRef50_Q131T0        Putative uncharacterized pr...    66     3e-10  1  12.2%   5:160  51:198     ----YLARVQERREAYVARLCKRAEVPFFLPL--VWNRRKNDWAC----LWPGQIAV--SLATKKRLSWIETQSVVTQLERCNSSVLEQMRGIGVFNRRAFDGVLSELGPIAGKTVGEIAGPFSEARSKRISKIDDTRVKYTVEHLGRTVQAILPIEALR--    
330 UniRef50_C7XGA2        Putative uncharacterized pr...    65     6e-10  1  16.2%  11:146  58:198     ----------SRRERR-----GEALFEYFSPSYVEARKVGGKMVNTKRPLLYNYVFVHAS-EDEIFRLKRTLP-LYNFlgGRSYFPYLSDREMDTLRWVAASYSNELPVYVPddRVRITSGPFTDMEAEVVVQPGGGHKDVMVRIL----------------    
331 UniRef50_B5ZVK1        Putative uncharacterized pr...    65     6e-10  1  14.0%   3:138  28:179     --DWYAIRAAPggESIIERNLRNEGISVYMPAFWYESIHHRTRKVIQrpLLVGYAFVN--LENMNFEQVRDVDGVICFLRSEFGPIRFSGDDLSVIAAEELSRRQEFRRERITRIQKETASQAMQLRGNLRKILPKGR------------------------    
332 UniRef50_A7V3C8        Putative uncharacterized pr...    65     6e-10  1  23.8%    1:63   13:75     MMCWHALYTAPKSEHKLMQRLNAAGYTTYCPMQAVFVKWKGHTRKVITPLFSGCLFVAGNVSE---------------------------------------------------------------------------------------------------    
333 UniRef50_C9LF34        Putative transcriptional re...    65     9e-10  1  14.2%   3:143  37:186     --DWSYFFTHNARLKHIAQKLKADnfPTFVHQSCKYIRNHDKVCKQLRPTISGLIfvEAYFKERLPELHLACDYATRCV------ARIPHAVMQPFMKIAELDahPFEHYAGSQLVRITSGPMTGLEGYIIRIDRDRKLVLRV-------------------    
334 UniRef50_B3JI43        Putative uncharacterized pr...    65     1e-09  1  15.2%   3:160  15:182     --QWFAMSAYKN-EKKAEEMLkkDGLEYFIPKHYAVRVYHGVKSKRLVPVIPNLVFVHASRKQITDFK--KKYNFLQFMMWEkkYIVVPDKQMESFIKIASQYEENTIYYKPEEiiCIYGGKFNGVKGVFmgKRRRRVVVMLEGIMG--ISVEVHPDLIE--    
335 UniRef50_Q1GG09        Putative uncharacterized pr...    64     1e-09  1  15.7%   2:160   1:186     -MTWYLGRTTTRheFAVERQLRALGIEAHAPRRIEFKRVGKKrePITSAYLPGYIFAEIPASMFTRAilMAVPAQEVLHHVKPFIAKVKSENADAERIIESRDRAAMCQFQPGEALDVLAGPFAERLVKFTRmdSYPMIEAQIEILGRLTRVKIDPLDVR--    
336 UniRef50_A6L935        Putative transcriptional re...    64     2e-09  1  16.4%   2:160  39:218     -KHWYIAIVNNKSEKLCRDKLEKRiyEVYIASQKEmlLPSGKRKQVDRIVFRSIVFIRCT-DVLRRKEIVHLPYIKRFmsGGIRPVaiPDEQMVKLRRMLDDSEEppRPLPLGARVRINGGKLHGLEGNVLEvdGNLNFVIRVDLLGCA-KVNITRDLLE--    
337 UniRef50_B9QXN0        Transcription termination f...    64     2e-09  1  20.4%   3:159  28:205     --EWVVIHTNPKCETRARDGLLGAGLLAFLPMEQIERRHGRGRKvvIRPMFPRYLFAGMDVKkqSVDQIRACDGVKGVLSFDKTGAVARVAVSDLIKILedGQMADVARLKEGAVVKLVKGSWCGQDLTVTGYdaKERVIGELTGSAMRLAVTAPLDAV---    
338 UniRef50_C6A1F2        NusG transcription antiterm...    63     2e-09  1  16.7%   5:160  10:147     ----FAVRVTVGQEENTAKLIYSKAKTYSLPIMAILSPSK----------VRGYIFVEATEKAAVDEVIRGIRHAKGTL-----PGPISFIEIEHFL----EEKPAVSGFEPGDIVELIAGPFKGEKAKVVRVDESKD-EIVVELIgvPIPVTVRGEYVR--    
339 UniRef50_Q94AA3        AT3g09210/F3L24_8 n=6 Tax=r...    63     3e-09  1  13.5%   3:106  97:217     --QWWAVRVSrgHerALARQFPEMEFTVYAPSVQVKRkkNGSISVKPKPVFPGCIFIRCILNKEIHDSIRDVDGVGGFIGSknKPRPVDDSDLEAIFKQAKEAQEK--------------------------------------------------------    
340 UniRef50_D1PI13        Putative transcription term...    63     4e-09  1  13.1%   4:140  50:198     ---WYVAVVRVNCETRIADSIRINlfDYWIPKVKVVykRSNKRKVKEKLFLSTFIFCNVSPRQLDKIRFRSDVYKMLTMPGQRKIYQIPDQVVANYRYFVENDEEppVPLKKGIKVRVVAGSMKGVEAYVQSYNGKKAVI----------------------    
341 UniRef50_Q8EUN7        Transcription antiterminati...    63     5e-09  1  19.4%   3:105  19:161     --KWYIVTSINGNEDTVYKNIEDKviEVFDPiiTWETLPGGRYkiREINRFPGYIYIKMIMEDDAWYVIRNTFGVTGFVGSSgkPIPMSDIEVANLFNPEMNQDI---------------------------------------------------------    
342 UniRef50_C7DH82        NusG antitermination factor...    63     5e-09  1  18.7%   5:154   3:132     ----FVVKVTSGQENIAANILQSKLSKGDAPIYSIIVIEG----------LRGYIIVEAQDELACRNFITKERSIKGII-----PKPMDPADVEKLIATKSTAQ----DISRNDIVEFTSGPFKGYKAKVLKVD-ELKSDITVELMDVVVPIPI--------    
343 UniRef50_Q6VE90        Orf37 n=2 Tax=Pseudomonas s...    63     5e-09  1  21.7%   1:152   1:153     MSNWYLINHNPKAVQGIIFRIRALGAevYSPANLKITKRLDcvRTSETQLFPGYLFVKLNPEVLHTSIVLQVSGVKKFVSFGGVLATISDCLIEAIKSSLLVRVDKKVTQIECRGVQ--PELLVQLESITLIRSSLDRQAALFKLLQEESRI----------    
344 UniRef50_Q2NEV9        Putative transcription anti...    62     6e-09  1  16.7%   5:160   3:140     ----YAMRVLIGQEKNVASLLAQ----------SVKHEDTGISAILSPESMKGYIFVESDKTLDMRHPALKVPNLRGLVEGD-----VDFDELKSFLSP----DQSIVNIEKGSIVELTSGPFKDEKAKVVRIDEAKE-DVVLELIEAAvpVTVKGDQIR--    
345 UniRef50_Q8ABS3        Putative transcriptional re...    62     6e-09  1  11.2%   3:162  40:221     --SWCYLFIHHAKVETVSKKLQTEQYRIFVHKSIVYKRGNKRIKKEEQATISGLVFIQGDANRIQKFLKENFFNLYLvdCSTGEIAAIPDSVMQPFMrrIRFMPHSFDYYSVGnlVRITSGILSGLEGYRIRISRDKCLVTSIGGMTVAiyVRLRRKQLEKI    
346 UniRef50_B3T614        Putative KOW motif protein ...    62     6e-09  1  15.4%   5:160  87:224     ----FAVRTTGGQEKIVMRLLEARI---------KMEKINIQSVLLLSDL-KGYVVVEARDVSAMFDAIQGIRHIRGQLRGE-----LTYKEIDKYLIKKS----TVSELAVENTVEIIGGPFKGMKATIteLEKEEATVILLDA-TYELPVTVDANYLK--    
347 UniRef50_Q6L1X2        Hypothetical transcription ...    62     8e-09  1  16.6%   6:162 133:282     -----IAKCTIGKELDTAVDLSAKA-ETDLKERLISNkrNEILSIMSPYEIKGYIFIETMHVDRVEYLARTLRNFKGIISGT-----VSMDEIEHYLTP----KPAVSGLSLGDLVEIVGGPFKGERAKIMSIDASkeVTVQLTESMVPIPVTVKAESIRPL    
348 UniRef50_A9SPI1        Predicted protein n=1 Tax=P...    62     8e-09  1  18.1%   4:158 119:326     ---WYMVSTPKKAEHEAAEQLHIqkYEVLTPSIPSFRkkSGRYSDSRVRLYPGCLLIRCVMNRDVYNMIRSNLRIYNFFGTKAqpSAVSIIEIEELFRKMEEAepPPPTIEKGALIRINVGPFINHTGIVNYVDHeeTVQLSVVIFGQSTDAELRIDE----    
349 UniRef50_Q11LV0        Putative uncharacterized pr...    61     1e-08  1  13.1%   2:146   1:181     -MTWYAIRTVPGAQkaVERALSEAGYVHYMPAERRlrKHTDLWKARRFAMLVGYVFVKGPVD---FRALEPVPGVHSIVGICGRPMEIDLLDILTLRSMeaEEKFDRDARVARKTIRIKSKKDARLKKIVEKLERADDLVVSLDVV----------------    
350 UniRef50_C6JAQ8        Putative uncharacterized pr...    61     2e-08  1  14.0%  69:161   5:100     --------------------------------------------------------------------LRKVIGLTKLIGTGDEIVPLVQEEIDLLMKIGTDKQLVEMsiIENDRVQILAGPLMGMEGNIRRIDRHKRTalEIEMFGRTVEMKGGLEIIRK-    
351 UniRef50_A8UUU2        Transcription antiterminati...    60     2e-08  1  18.6%   4:159   2:195     ---WYVLKVRSGKEEALKELLG-RDFEVLYPSRKKLNvvNGKKRYSfeSPLRGYLFVKGRYEDIL-SKTENLLDVVGFLIMGGKVRTLTDEEVSDLQKRVEKGERLKTLLPERgrVKVVSGEWTGAEGVIEEVYEDLSLKLKLRLWDKTFTAILPLERV---    
352 UniRef50_Q74M56        NEQ540 n=1 Tax=Nanoarchaeum...    60     2e-08  1  13.5%   5:160  18:155     ----WIVKTAGGKEEIVADLIEAKA----------KKLGANVYSIVIAPGIKGYIFVEADKYDTVNELVHDIKHVRKVL-----PKPIEVKDIEKFIKAE----PLVTKVNVGDIVEVIAGPLKGSRGKVVAFN-ENTGEVTIETLDSVipVTVSIHDIK--    
353 UniRef50_B7KSX1        Putative uncharacterized pr...    60     2e-08  1  12.6%   3:161  46:236     --KWYVCTTAPSRELSAAASVRQapFAAYVPCEFFWHRAIRsrREIQRPILRHYILVglAALRDRDREGRNVHGLAGILGAPggPLAMNGEGLRWLRAQGEDEIAGATniQPGEDVRAGSGVFSGFLGKFIGTAEGGTvvIALDMRSTSCEVRLPIEDVHR-    
354 UniRef50_O27714        Transcription termination f...    60     3e-08  1  16.7%   5:160  19:162     ----YALKTSVGQEKNVARMLARKVRDSGI----------EINAILVPESLRGYILVESSSKIDMRNPAIRVPHLRGVVEstEGEAEIDFEEVKRFLKPE----PIISSIKKGSIVELISGPFKGERAKVIRID-ESREEVVLELIEAAvpVTVKGDQIR--    
355 UniRef50_B8IRQ9        Putative uncharacterized pr...    60     3e-08  1  15.8%    3:97  56:148     --RWHAAVTFPGCEVKVRDAMQLRRIDTVLPMVRFWRIRSRKRFVAERPLLARTVIFGLDHACQDIAGIEGLERVVR--GASVGWADLPEQDVYDLR-----------------------------------------------------------------    
356 UniRef50_Q8TX53        Transcription antiterminato...    60     3e-08  1  17.9%   5:160  10:154     ----YAVRVQAGREEATADMLVMRARR----KVKEEGIETGLKAVIAPEELRGYVIIEVelTDELRDLIHDLPDTRGIVE-----KPMDFEEIEHYFAPKPEAVE----ISEGDVVEILSGPFKGEKARVVSVDESRR-EITVELLEAPvpVTVKMDALR--    
357 UniRef50_Q7NAK3        NusG n=2 Tax=Mycoplasma gal...    59     4e-08  1  11.6%   3:140   9:188     --QWYIATTTNGNEDSVIKTLKAkiFDSNNPTHNIPATMRnkYKITDTNKYPGYIYIKMEMNEAAWFAVRNTVNITGIVGSSgkPIPISSSEELDLLNGESFDQNYRIVITPNAIIEMDRNLFNERGELILDENAAKTIV----------------------    
358 UniRef50_D2MG88        Putative uncharacterized pr...    59     4e-08  1  17.1%  17:162  25:186     ----------------VRRLQDELGLAPYLPMEWKSVAarGRRREVQVPLLIGYLLLPEalAHGRYGDVLATRGVRGLLHYAGspARLSDATVERLRAEERAADNKRQmwQPGDEVWAEILPGRSLLARIseKAPRGRIAILleVLGRR-AFAVEPKQLQRV    
359 UniRef50_D1JE94        Putative transcription anti...    59     6e-08  1  13.5%   5:160   5:145     ----YAVKTTVNQELAVATMVEGALGE-------EGVKDHGIKAIMVPEELKGYLLVEASFPEALEQIIQSIPHARGLVKG-----VMGLEEVEHFLTP----KPSVTGILEGSIIEIVSGPFKGERARVKKVDehEEITIELFEAMVPIPVTVRGDSVR--    
360 UniRef50_A3AP86        Putative uncharacterized pr...    59     6e-08  1  16.5%  30:162 267:388     -----------------------------IPVEEVESIIREEKEEQERV-------------DREFEEMEN----GGIVESFNKPVEDSekIKRQFKKPISKGGSNHNAFTPGASVHVLSGPFEGFTGSLLEVNRkkKATLQLTLFGKESFVDLDFDQIEAV    
361 UniRef50_Q57818        Putative transcription anti...    58     1e-07  1  17.3%   5:160   3:140     ----FAVRTMVGQEKNIAGLMASRA----------EKEQLDVYSILASESLKGYVLVEAETKGDVEELIKGMPRVRGIV-----PGTIAIEEIEPLLTPKKIIE----NIEKGDVVEIIAGPFKGERAKVIRVDKHkeVTLELENAAVPIPITLPVEGVK--    
362 UniRef50_UPI00016B21AA transcription antiterminati...    58     1e-07  1  13.6%  97:162    9:75     ------------------------------------------------------------------------------------------------KRMGVEEPKHQIDFEEGEVVSVIDGPFKGFDGTISEIDtkGKIKVMVSMFGRDTPVELDALQVKKI    
363 UniRef50_UPI00003C8438 transcription antiterminati...    58     1e-07  1  18.1%   6:160 146:293     -----IAKCTIGKELDIAIDLSNHAERD---REERMAMNKNARNEVMAVMSpgYFFIETMHADRVDVLSKSIRGFRGFVSGD-----IDISEIEKYLTP----KPAVTGLEMGSLVEIVEGPFKGERAKITAIdaKEEVTVQLIESMVPIPVTVKAEAIR--    
364 UniRef50_UPI0001BCE1C5 transcription antiterminati...    57     2e-07  1  23.1%    3:67    4:77     --KWYAIQTYAGSEMSVKRAIENLVveVVVPTEDVIEIKNGKQKINEESLYPGYAFAPFRSRHITFA-----------------------------------------------------------------------------------------------    
365 UniRef50_Q12UQ1        LSU ribosomal protein L26e ...    57     2e-07  1  12.7%   5:154   8:137     ----FVVKTTANQERSVAAMLAQ----------VAKKENLDIRSIIAPDELKGYVLLESSDSGAVEQAIQTVPHARTVVKGQSTIA-----EIEHFLTP----KPTVTGIVEGAIIEVTSGPFKGEKARVKRVD-EGHEEITVELFDAVVPIPI--------    
366 UniRef50_C5SIV6        Putative uncharacterized pr...    57     3e-07  1  15.4%   2:157  21:173     -RAWLIVTTYAKKEAVVLSQLKGIGYEGYRPMIAKRRKIAGQEAPVLVplYPNYVFVRALEG----RSPLSLFGLQGLACVHER--AVLDAVVQAHRAKEADgkNEGKAFRRGDRIKTLGGLL---EVVLSDPIDTNRCAALSSFMNGSSRLIVGLD-----    
367 UniRef50_D2EF56        NusG antitermination factor...    56     4e-07  1  14.7%   3:158  11:145     --HFFIIRVTIGREMQALERLQSQ-----------LARVNGIYSIVKPYSLKGYIIVEADSRESISNLIYNIKHIRGIMN-----KELSKDEA----LKTIEKKKQNIDINIGDVVKVLSGPFKGETATVKAVNKEKE-ELTVMFLESAVPINVNIKI----    
368 UniRef50_B5IAH1        NusG antitermination factor...    56     5e-07  1  14.8%   6:154 133:262     -----AVKTTIGQEVKVARDIG---------MKAKIHGWKEIFSVLAPYNLKGYVFVETSRPDKVLSLIRGIKDAKGVVRGE-----MHLEEIKHYLTPTPTIHR----ISVGDIVELVEGPFKGEHAKVIQIDEAKD-EITVELFEAMVPIPI--------    
369 UniRef50_P36262        Transcription antiterminati...    56     5e-07  1  16.9% 104:162   10:69     -------------------------------------------------------------------------------------------------------PVSSVFFEVGERVCVSDGPFASFNGIVKNVDEEkrVHVEVVIFGRVTPVELAYNQVEKI    
370 UniRef50_Q978E9        Transcription termination-a...    56     6e-07  1  18.1%   6:160 138:285     -----ALKTTVGSEVQVATDLNNKA------ERDRDERSQGGEKQPSEVfiKGYIFVETMHPDRISYLAKDIRGYKGMVSGK-----IDLEEIAHYLTP----KPAVSGLELGSLVELVEGPFKGEKAKIISIDskEEVTVQLVESMVPIPVTVKAESIR--    
371 UniRef50_Q9Y9W3        Putative transcription anti...    55     9e-07  1  15.0%   3:162   8:149     --RFYAILVTSGAEVNVATIIAERARALGL----------DIRSIIVPPRIKGYVILEAHDPGDVYDATRGLRHVKR-----RRPLILKFEEVMKLVKPEVEIPA----LKPGQVVEIVAGAFKGMKARVIDVNQSKG-QVTVSLLefRATATIPIDEVRPV    
372 UniRef50_B0NND0        Putative uncharacterized pr...    55     1e-06  1  18.8%    4:72   16:84     ---WCIVLTAPHAELNIQKKLEQQGFITYVPTISVRRSWAGCIKEIHIPTIARCVFVYATKEEMQEMQKEYT------------------------------------------------------------------------------------------    
373 UniRef50_Q54017        AnfA1 n=2 Tax=Serratia ento...    54     2e-06  1  28.9%    2:98   3:109     -KKWYLIRCNYGKIDLGQKSLETYgfEGfaPNLKPSLEFEGFYLTFQKNFfpPYLFVRFDIDHIPISKIQHAIGVKGFVRFGGGIKSIPDIVIGKIMK----------------------------------------------------------------    
374 UniRef50_Q48B18        Transcriptional regulator n...    53     3e-06  1  34.5%    1:84  73:158     MKNWRVLMHNSSVYQSLITSIERLDVEVYSPESITYRKRPDRPSSVETklFPGYLLLRFDPEVTHTTTITALNGARGFVQFGGQ------------------------------------------------------------------------------    
375 UniRef50_B3C5U6        Putative uncharacterized pr...    52     6e-06  1  14.7%    2:69   14:81     -RNWYIVLTSPWKEKKIREDLDNKGIISHLPTTYVQYKWKEKIRKIQIPTVNRCIFIYATDSEIKTLRV---------------------------------------------------------------------------------------------    
376 UniRef50_Q4WP96        Transcription elongation fa...    52     7e-06  1  17.5%   7:143 246:371     ------VRCKAGKEREV----------VFAIQKRIEERPPGSRKPIRIiaMSGYIYVEARRQADVMEALEDMSNVY----PRTKMILVPVREMPDLLRVQKSEE-----LNPGGWVRIKRGKYQGDLAQIEEVDTNgdVTVRL-------------------    
377 UniRef50_B8BT45        Predicted protein n=1 Tax=T...    51     8e-06  1  16.2%   3:162  79:276     --QWYLINCVAGIELdaQARLVTKDFpiVVPVERHLRSHGDKKKVVDVkrYPGYVFCKIRLTEDVyrSWMGTVNRKGHKKLPPAPLPLPDEEVKKFKGLEEKQELFEDMfeVGQMVKVLSGNFEGEDGTVRRL-KDGQICVRMFTYGQTFDNWFDPTAIRPL    
378 UniRef50_UPI000197ADA0 hypothetical protein BACCOP...    51     1e-05  1  12.2%   3:150  39:191     --SWCYLFVHHAKVETINEKLILK-FKTFIHKSIAYKRGKSHVRKTERPTISGLIFIQGNSREIQNYLNQIAFDLYLvdCSTKKTAIIPDRVMQPFMQLSQINPHHIRFMPHstLIKITSGVLTGMEGYCIRIARDK---CLVTTVGNMT------------    
379 UniRef50_A0RUG2        Ribosomal protein L24A n=1 ...    51     2e-05  1  19.1%  51:160  26:127     --------------------------------------------------LKGYVVVEANDPNAAYQATDGVRHIKGQLRGE-----LDFKDIEGYLVKKS----TVTSLEKDQTVEITGGPFKGMKASITRIDHEkaTVVLLDA-SYQLPVTVDANYLQ--    
380 UniRef50_A4RYW5        Predicted protein n=2 Tax=O...    50     3e-05  1  16.1%   4:158  28:258     ---WYMLEVPETRENQAKAAILALnvVAWVPRvyVAEEDAVGKSELeeMLQPGYVLVRCALTQELMDAFDDLRSVRGFATGGSspVVKTEADIEAEKAREQAKEVMRAERGDedRVEVHTGPFKGFKGHIVARNDDGSVEATLAIFGRDTNVSLAADE----    
381 UniRef50_B1L6L1        NusG antitermination factor...    50     4e-05  1  21.8%   5:146   9:131     ----FPVRVISGKEINIMRLL----------VSRVSSTGAKVRSIIFVPKFKNYLFVEAEREYEVRKLIAGLSKLRL-----ASSSPVPPQEIEDILSSETAGME----IEPGDIVKIIKGNFKGYRAVVIATPEGKSKMLTLKLL----------------    
382 UniRef50_C1FFC9        Predicted protein n=1 Tax=M...    49     5e-05  1  18.4%  87:162 513:591     --------------------------------------------------------------------------------------PIVGEEAMALRDAAIRPGAATATGAGAASIEVVAGPFKGFKGYVtkPRGDGAVDAKLVIFGRETDVTLEAGEFETL    
383 UniRef50_Q92W20        Putative uncharacterized pr...    49     5e-05  1  14.3%   14:90    2:79     -------------ESIIERNCRKDGFDIFMPSFYTELRHHRTKQILQkpFLVGYGFVSLPR--LNFEELRRVDGVVCFLRGAngPLEFPD------------------------------------------------------------------------    
384 UniRef50_C2HWG3        Transcriptional activator R...    49     5e-05  1  29.7%  97:160  65:128     ------------------------------------------------------------------------------------------------LDCEQLKHATKQLPEKGQTVRVARGQFAGIEAIYLEPDGDTRSIMLVKMISQQVPMSIENTDWE--    
385 UniRef50_B8I2J4        NusG antitermination factor...    48     9e-05  1  16.4%    1:73    1:77     MNNWFVFRVQIGEEYKACEFlkEESVE-FVPQVEVVTKNSQSIRKELTPTFPGYVFTGSILKEKTFVDLAYLY-----------------------------------------------------------------------------------------    
386 UniRef50_A3TRT6        Putative secreted protein n...    48     9e-05  1  21.3%  85:159 361:434     ------------------------------------------------------------------------------------PVPLPK--ITATPLPSTTVAVDPDPFSPGDTVKITAGQYLGLSAKVLKVDtkNTVTVEVVVLGIKLPVVLPYSSV---    
387 UniRef50_B5JIS7        Putative uncharacterized pr...    48     1e-04  1  18.9%  86:159    1:78     -------------------------------------------------------------------------------------MVVEDEVVDLIKENSEdsPAVDDSFQCGENVEVLEGPFQGMMGTVLqlNEGSRVAILLTLLTSETKVTISRSHL---    
388 UniRef50_P75049        Protein MG054 homolog n=2 T...    48     1e-04  1  14.9%  42:128  84:168     -----------------------------------------KVKISEKNLLGRYIYIKMIYSEDAWRIIRNFPGITGIVGSSGrpTPLDQADADNLEQMLKG-----ISVNPKKRVLVTNTAIVEMDA----------------------------------    
389 UniRef50_B5HX00        Putative uncharacterized pr...    48     1e-04  1  22.0% 108:157    4:54     -----------------------------------------------------------------------------------------------------------PDIAVGASVTITDGPFATLRATVTEIdpSQKVKGVIELFGRHAPVELSFT-----    
390 UniRef50_B8ICP2        NusG antitermination factor...    48     1e-04  1  23.3%    2:61   38:97     -RRWYVVRIDPTRERKIREGLETAGFATCVPASSAVIEHRGRYRETRRRAVPGYLFVGADR-----------------------------------------------------------------------------------------------------    
391 UniRef50_UPI0000382CEE COG0250: Transcription anti...    47     3e-04  1  16.7% 101:160    1:61     ----------------------------------------------------------------------------------------------------EVQDFVETLFAIGDEVRITDGGFATFMAKVEKVdkRGRYTVAVDVFGRPVPFEIAEESLE--    
392 UniRef50_A7VAG7        Putative uncharacterized pr...    45     6e-04  1  16.1%    4:65   16:77     ---WNIVLTGQHAEPRTKAMLEAKGIITWLPLAPVRRQWGRILKEIHTPVIPRCVFVYISNEERN-------------------------------------------------------------------------------------------------    
393 UniRef50_D1PC69        Putative uncharacterized pr...    49     6e-05  1  11.1%   4:138   2:183     ---WFIVKTDVFSEQQSIDFLREkiTDFYFPlrKTYKNENGEVKVRFVPVLQGMFFIRV-QNERRLKKVLSPYGYFMYKGFEMEpsKIPDEDMETFVYFNDreKRYSDLVKENDTIRILSGPLAGRVGVVKQIKHKGK------------------------    
394 UniRef50_Q6BZG0        Transcription elongation fa...    46     5e-04  1  15.0%   5:137 249:367     ----YAIRCTPGREKDLVRKLYEKK------RTLARSNPLEILTVFQRDSFKGYIYIEAKKPEAIERALTGMVNIY-----AKQRLLVPVREYPDLLKQVKSSDVE---IVPGIYVRITRGKYKNDLAIVDNLSENG-------------------------    
395 UniRef50_UPI0001743F0E transcription antiterminati...    45     0.001  1  20.8%    2:25   16:39     -KKWYIIHTYSGYEKKVAADLEKRI-----------------------------------------------------------------------------------------------------------------------------------------    
396 UniRef50_A8ABQ4        NGN domain protein n=1 Tax=...    45     0.001  1  13.3%   5:162   6:145     ----FPVRTVSGREIDVALLIEERARA----------KNLDVKSVIVPPRIKGFVIVESP---AHFVVAEAVRGIKYVRGGPGK--KISLEEVLKMIKP----VPIIETVEVGDIVELVAGVFKGVKARVekIPEKNELVLSIVEAAYPLQITVPADYVRPV    
397 UniRef50_D2VQ68        Predicted protein n=1 Tax=N...    44     0.001  1  13.6%   5:144 125:259     ----FLVKCKQGKEKEAVMTLLQKHFSV------KHSPNKKDRLLITSAlfKGKIYIEAQKEVHVRHAIEGLSHLI----YESGIKLVPLKEMPDVLNVNQLSTKIQD-ISVGKWVRVKRGTYKGDIGKVHDVDKARgvVVLVP------------------    
398 UniRef50_P27692        Transcription elongation fa...    44     0.002  1  14.3%   7:146 290:417     ------VRCRPGKEKELIRKLLKKKFN--------LDRAMGKKKLkqRDNYTGRIYIEAPKQSVIEKFCNGVPDIYI-----SQKLLIPVQELPLLLKPNKSDDVA---LEEGSYVRIKRGIYKGDLAMVDQIS-ENNLEVMLKIV----------------    
399 UniRef50_C1N286        Predicted protein n=1 Tax=M...    43     0.003  1  20.9% 116:158 422:464     -------------------------------------------------------------------------------------------------------------------IEVQEGPFKGFKGYITGNNTNGSVEARLLIFGRETSVTLAADE----    
400 UniRef50_A8HQJ4        Global transcription factor...    43     0.004  1  18.3%   2:143 170:299     -KLW-LVTCKVGHEREAVVQLLQK---CYTMAERGTPLR--IMSAVALDHLPGFIYVEAAKESHVMDAIRGLRTVY--IGRGAKLVPLNE-----MVDAVTVNKKAKDDMARDTWVRVRSGLYKDDLARVVEVDsaGRAVVKL-------------------    
401 UniRef50_O80770        Putative transcription elon...    43     0.005  1  17.6%   2:143 170:295     -KLW-LVKCAIGREREVAVCLMQKIVD-----------RGSEFKIRSAIalQNYVYIEADMEAHVKEAIKGMRNIY----ANQKILLVPIKEMTAVLSVESKAI----DLSRDSWVRMKLGIYKGDLAQVVDVDnrKRVTVKL-------------------    
402 UniRef50_Q01WX6        Putative uncharacterized pr...    42     0.006  1  20.0% 110:159   27:76     -------------------------------------------------------------------------------------------------------------PRAGQRVRIKGGALAGVEGVVIGFRQSLRLILSITLLQRSVLLEIDRRLV---    
403 UniRef50_C6J5U5        Predicted protein n=1 Tax=P...    42     0.007  1   9.9%   5:115   5:136     ----FAIQVMTGKENNVKKLMenESAQNWIKAVHTFTTTTRRlkEIKRAIMPGYIFIEmhLPADVWHLIKSIPGVIKQ--FTGSGQVIGAEEFQKMLGLEPEEQQVEVAVPIQEQ-----------------------------------------------    
404 UniRef50_A6L4G6        Putative uncharacterized pr...    41     0.009  1  17.0%  53:140 159:255     ----------------------------------------------------GYLFVCAPLDELNLILAHLFPRQyaKDRNSYSVAVIPHRQMEEFinIELMDKPLEEYIQKKQKIRITGGVFQGKEGCIMRLHRNTKLV----------------------    
405 UniRef50_A4RZ64        Predicted protein n=2 Tax=O...    40     0.024  1  31.2% 110:141 319:350     -------------------------------------------------------------------------------------------------------------FMPGDQVIIVEGDLRNLEGVVERIDPDGRVVV---------------------    
406 UniRef50_Q6MDM7        Putative transcription anti...    40     0.026  1  17.5%    1:40    1:49     MYKWYVVQVLSTHEKKVKKALEEhiEQILLPTENVSEVKK--------------------------------------------------------------------------------------------------------------------------    
407 UniRef50_A7IAL6        Ribosomal protein L24 n=17 ...    40     0.028  1  13.5%   5:160  26:166     ----FAIKTTSKQERTVADNILKAI-ETKATDIKVTSI-------IVPNELQGYVLVETPEERNRIEQLVEMIAHARAVAKGQT----TLAEVGHFLIP----KPVVSGIDEGTIVELIAGPFKGEKAVVKRVdaKEEITVELYESVVPIPITVRGDNVR--    
408 UniRef50_A8MDC8        Transcription termination a...    40     0.036  1  14.9%   7:160  11:149     ------VRVIAGQEYNVAAIIRTR----LELMEKDKRKYYNVPSIVVPPNVQGQVYLETPH---SYVAIDLSTGIKQYRGLMMGKVPLTE---------LMKMIKREIKVQINDVVEIITEPFRGFKAKVVDVDEKNNTVKLL-LFDTAtpVTLPIKSIR--    
409 UniRef50_D0T981        Transcriptional regulator U...    39     0.052  1  13.4%  80:146   17:90     -------------------------------------------------------------------------------GGRSYFPYLSDREMETLRWVAASYSNELPVYVPddRVRITSGPFADMEAEVVVQPGGGHKDVMVRIL----------------    
410 UniRef50_B0EU05        Suppressor of ty, putative ...    39     0.055  1  12.9%   5:143 119:240     ----FAIRCKQGYEKDICMRikDRifSVFVPKEKT-----------------GIVYIEA-MTERKFAD--ACDGVRDLYINT--IHALNDKQIEELL-----VSRMPTTIEPNSYVRINAEPYKGDLGVVVETTENKKVIVKL-------------------    
411 UniRef50_UPI00016C0B0F transcription antiterminati...    39     0.057  1  16.7%    3:44    5:55     --KWYVVHTYSGYENKVkrNMQELIQKVEIPMHNEEEEKNGTTR----------------------------------------------------------------------------------------------------------------------    
412 UniRef50_A6UJ02        Putative uncharacterized pr...    39     0.062  1  10.6%    1:47  51:102     MKrwYPIRVAPGyeSIIERNCRKDGFDIFMPSFYTELRHHRTKQISR-------------------------------------------------------------------------------------------------------------------    
413 UniRef50_C4LVU5        Transcription initiation fa...    38     0.091  1  12.9%   5:143 119:240     ----FAIRCKQGYEKDICMRIMkhLFSVFVPKEKT-----------------GIVYIEA-MTERKFAD--ACDGVRDLYINT--IHALNDKQIEELL-----VSRMPTTIEPNSYVRINAEPYKGDLGVVVETTENKKVIVKL-------------------    
    consensus/100%                                                                                      ..................................................................................................................................................................    
    consensus/90%                                                                                       ......h....t....h...h...................t.........h.thlhh...........h.....h............h....h..h................tt.h.h.tt.h.t..s.h..........h.h...................    
    consensus/80%                                                                                        ..Wahh.s..t.c..h.t.ltt..ht.hhP.......httth......hh.shlhlph...t.....h.th.thhthht.tt....l..t.ht.hh...t........h..sp.l.lhtGshts..u.h.thp.ptphhh.lthht....h.h........    
    consensus/70%                                                                                        ..Wahlpshst.EppstptlppthhphhhPh.thhphhtsphphh...hhsuYlhlphthppt.h.hlpph.tlhthlt.stp.h.lstpphpthht..t.t......ht.GphVplhpGshtshpuhl.phptppphhl.lphhst.h.hpl....l...    

MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown